National Boards

Albania

EBTNA Reprasentative in Albania

Ariola Bacu

Prof.Dr.Ariola Bacu graduated in Biology in 1995 at University of Tirana, Albania, received DSPU and MSc in Biotechnology during 1998-2000 at the Center for Advanced Mediterranean Studies- CIHEAM, Greece, and obtained her PhD in Plant Molecular Biology-Biotechnology, 2003, at University of Tirana, Albania.

She worked at the Institute of Biological Research of the Academy of Sciences of Albania from 2000 to 2005 as a researcher, and form 2005-2008 as head of section of Molecular Biology. In 2008 she moved to the Faculty of Natural Sciences of the University of Tirana as the head of the Department of Biotechnology from 2008-2016. She is a senior researcher and lecturer in Molecular Biology and Genetic Engineering in undergraduate and post-graduate programs. 

As a researcher she was involved in molecular markers based evaluation of plant biodiversity; Characterization of gene families of importance for the production of secondary metabolites; Studies on modified expression of genes responsible for crops resistance toward environmental stresses, etc.

She has participated in more than 30 international and national RD projects, at 11 of them as coordinator, is coauthor in 5 monographies, author of many publications, two text-books for students, and supervisor of PhDs and MSc students.



Austria

Austria

Ines Swoboda

Ines Swoboda graduated in Genetics (MSc) in 1990 and obtained her PhD in 1995 at the University of Vienna. She was a postdoctoral research fellow at the University of Melbourne in Australia (1995-1998) and at the Medical University of Vienna (1999-2003). In 2004 she received her Habilitation in Allergology. In 2005 she established the research group of “Immune recognition” and in 2010 became Assistant Professor at the Department of Pathophysiology and Allergy Research at the Medical University of Vienna.

In 2011 she moved to the FH Campus Wien, where she is currently Professor of Immunology, teaching the subjects Virology, Immunology and Infection Biology to undergraduate and postgraduate students of Molecular Biotechnology. She also leads the research group of “Allergy Research”. After initial research in the field of Plant Molecular Biology studying the biological function of allergens in plants, she has been working in the field of Molecular Allergology for more than 15 years. Her research focuses on the identification and characterization of allergens, as well as on the development of recombinant allergens for improved allergy diagnosis and of hypoallergenic molecules for improved treatment of allergic patients.



Azerbaijan

EBTNA Reprasentative in Azerbaijan

Ilham Shahmuradov

He was born January 1, 1958. He is Head of Bioinformatics Laboratory,  Institute of Botany, Azerbaijan National Academy of Sciences and Professor in the Department of Medical Biology and Genetics, Azerbaijan Medical University. Scientific fields of interest are: structure and evolution of eukaryotic genomes; organization and expression of genes in eukaryotic genomes; organelle-to-nucleus gene transfer in plants; development of bioinformatics tools and databases.

He has published 60 papers. In collaboration with scientists from USA, UK, Russia and Pakistan, he developed a set of bioinformatics tools, including computer programs for identification of RNA polymerase II promoters and poly(A) sites. He is Secretary General of Azerbaijan Society of Biochemists and Molecular Biologists.



Belarus

EBTNA Reprasentative in Belarus

Alexander Kilchevsky

A.Kilchevsky@igc.bas-net.by

RESEARCH INTERESTS: Principles and techniques for ecological plant breeding with use of modern biotechnology approaches and methods aimed at developing high productive ecologically resistant plant cultivars. Engineering methods applied to plant cells. Education and training of specialists in genetics, molecular biology and modern biotechnology is under Prof. Kilchevsky intent attention too.

RESEARCH EXPERIENCE: Director, Head of the Laboratory of Ecological Genetics and Biotechnology, Institute of Genetics and Cytology, National Academy of Sciences, 2004 – present. Prof. Kilchevsky is also a head of the DNA-Biotechnology Centre and the Republican Centre of Genomic Biotechnologies at the Institute of Genetics and Cytology, National Academy of Sciences of Belarus. Prof. Kilchevsky has worked out the theoretical fundamentals of biotechnology in Belarus and developed above 15 tomato cultivars registered in the Cultivar State Register. He is a developer of some modified techniques for DNA genotype identification of tomatoes and sugar beet based on molecular markers. Significant research results have been achieved by Prof. Kilchevsky and his research team in the following areas: investigation of main principles and use of modern biotechnology techniques for ecological plant breeding, aimed at developing high productive and ecologically resistant plant cultivars; development of an effective seed-growing system for tomato hybrids based on the functional male sterility. Prof. Kilchevsky has revealed the basic regularities of genotype-environment interactions at different breeding stages and developed a conception of basic environment complex for plant breeding.

He was a principal investigator when some advanced techniques in plant cell engineering and biotechnology were worked out in Belarus. They are as follows: gametic methods of tomato breeding for resistance to biotic and/or abiotic stresses; optimization of the basic stages of some cloned cultivars; methods of tomato marker-assisted selection for genes determining fruit quality and shelf life.

EDUCATION Dr. Science in Biology, Genetics Diploma of Doctor of Science in Biology ?? ? 001354 issued by the Higher Certifying Commission of the Russian Federation on May 6, 1994, N21g/15. Ph.D., Genetics PhD Diploma ?? ?009768 issued by the Higher Certifying Commission at the Council of Ministers of the USSR on September 29, 1982 in accordance with the decision made by the Academic Council of the Institute of Genetics and Cytology, National Academy of Sciences of Belarus, of May 31, 1982. M.S., Biology Diploma with Honors ?-I ? 011390 issued by The Belarussian State Agricultural Academy on April 29, 1977.



Belgium

EBTNA Representative in Belgium

Prof Vincenzo Costigliola

Vincenzo Costigliola graduated in Medicine from the University of Naples in 1972 and with distinction, in Anaesthesiology and Intensive Care from the University of Pisa in 1978. Completed studies in Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drugs Abuse, Emergency Treatment, Disaster Action, Hospital Organization, Medical Teaching Methodology and Computer and Audio-Visual Training for the Medical Profession. Professional experience ranges from senior military positions as Chief of Medical Services in the Italian Navy, responsibility of the outpatients clinic of the Shape Hospital in Belgium and since 1972 family practice in Italy and Belgium. Medical advisor: OTAN; W.E.U. Bruxelles.

Member of the International Adisory Board at King Abdulaziz University J Djeddah Saudi Arabia President of EPMA (European Predictive, Preventive, Personalized Medicine http://www.epmanet.eu/ President of E.M.A. (European Medical Association ) http://www.emanet.org/ President of E.D.A. (European Depression Association) http://www.eddas.org/ President of I.R.M.A. ( International Rescue Medicine Association ) http://www.irmanet.eu/



Brasil

EBTNA Represantative in Brasil

Paolo Bartolini

Paolo Bartolini

pabartoli@hotmail.com

     Ph.D in Chemistry (Pavia, Italy, 1969), Post-doctorate in Biochemistry (University of Iowa, USA, 1971-74), Post-doctorate in DNA Recombinant Techniques (University of Pavia, 1988-89). He is an Italian citizen, resident in Brazil.

     He has been working at IPEN-CNEN/University of São Paulo (Brazil) since 1975 as a teacher and post-graduate program supervisor, carrying out researches especially in the field of the “Synthesis, purification, characterization and applications of pituitary hormones obtained by DNA recombinant techniques and of animal models for gene therapy”. He also carried out 17 working stages or scientific visits in 9 different countries, being responsible for about 20 national or international research projects. He is still the Scientific Supervisor of the Hormone Division of the Biotechnology Center of this Institution. He published 87 papers in major international journals, 11 book chapters and deposited 5 patents related to products or processes. His publications in the ISI Web of Science can be easily seen entering with author (Bartolini P) and address (Brazil).  



Bulgaria

EBTNA Representative in Bulgaria

Dancho Danalev

POSITION

 

Associated Professor at University of Chemical Technology and Metallurgy, Sofia, Biotechnology department

 

WORK EXPERIENCE

 

 

2015-

Consultant in  Digital Marketing Group for Essentica project

http://www.digital-marketing.bg/en/; http://www.essentica.eu/

▪  responsible for the proper terminology presenting of information and forms part of the texts.

Business or sector  Private company,  Offer effective solutions for planning, creative, development and analysis of integrated marketing and communication strategies combining traditional and digital technologies.

 

WORK EXPERIENCE

 

 

2012-

Associated Professor at University of Chemical Technology and Metallurgy - Sofia,

Biotechnology Department

University of Chemical Technology and Metallurgy, Sofia, Bulgaria, 8 Blvd. Kliment Ohridski,  http://dl.uctm.edu/en/

▪  lecturing, participation in academic structures of the university (including academic council, faculty council, department council), heading of PhD students, work with students, creating new teaching plans, development of new courses in accordance with the dynamics and needs of the environments

Business or sector University, technical direction

 

WORK EXPERIENCE

 

 

2002-2011

Assistant Professor at University of Chemical Technology and Metallurgy - Sofia,

Organic Chemistry Department

University of Chemical Technology and Metallurgy, Sofia, Bulgaria, 8 Blvd. Kliment Ohridski,  http://dl.uctm.edu/en/

▪  practical exercises, participation in academic structures of the university (including academic council, faculty council, department council), heading of bachelor and masters students

Business or sector University, fundamental direction

 

WORK EXPERIENCE

 

 

2005-

Consultant in Testing centre GLOBAL TEST

Testing centre GLOBAL TEST,  Bulgaria, 1618 Sofia, 31 Krushovski vrah Str., http://www.globaltest-bg.com/en/

▪  Development and introduction in a practice of new methods for extraction and analysis of physiologically active substances

Business or sector Private company, Analysis of biological active substances

 

EDUCATION AND TRAINING

 

 

19-25.01.2015

Scientific exchange by ERASMUS+ project

Replace with EQF (or other) level if relevant

Ecole National Superieur de Chimie de Rennes, COS team,  http://www.ensc-rennes.fr/themes/recherche-valorisation/cos/

▪  Work with students, Ph.D. and postdoctoral students

 

EDUCATION AND TRAINING

 

 

1-15.12.2014

Invited Lecturer

Replace with EQF (or other) level if relevant

Shakarim State University of Semei, Kazakhstan, Chemistry Department,  http://www.semgu.kz/

▪  Teaching courses of organic and bioorganic chemistry for master students as a part of exchange program for trilangue education

 

EDUCATION AND TRAINING

 

 

4-9.07.2013

Invited Lecturer, Summer school “Innovation and technology management in medical and pharmaceutical biotechnology”

Replace with EQF (or other) level if relevant

Alma Graduated School, Bologna, Italy,  http://www.bbs.unibo.it/hp/en/

▪  Lectures and work with master and Ph.D. students

 

EDUCATION AND TRAINING

 

 

2010

National Certificate qualification from French teaching high education system, certificate № 102322204411

Replace with EQF (or other) level if relevant

French education system

▪  The obtained certificate gives me the opportunity to postulate for different position in the High Education system in France

 

EDUCATION AND TRAINING

 

 

09.2009-07.2010

Post-doctoral position

Replace with EQF (or other) level if relevant

University of Cergy-Pontoise, France, PeptLab-SOSCO  Laboratory,  http://www.u-cergy.fr/fr/recherche-et-valorisation/laboratoires/lcb.html

▪  Training in the field of carbohydrate chemistry

 

EDUCATION AND TRAINING

 

 

01.02-31.07.2009

Invited Lecturer

Replace with EQF (or other) level if relevant

University of Cergy Pontoise, France, ECIME Laboratory,  http://www.u-cergy.fr/fr/recherche-et-valorisation/laboratoires/satie.html

▪  Cover courses of HPLC, practical exercises of organic chemistry and seminars of theoretical chemistry

▪  Scientific training in the field of new materials obtained by sol-gel technology

 

EDUCATION AND TRAINING

 

 

15.10-15.11.2008

Invited Lecturer

Replace with EQF (or other) level if relevant

University of Cergy Pontoise, France, SOSCO Laboratory,  http://www.u-cergy.fr/fr/recherche-et-valorisation/laboratoires/lcb.html

▪  Training in the field of carbohydrate chemistry and biochemistry

 

EDUCATION AND TRAINING

 

 

09.2006-07.2007

Post-doctoral position

Replace with EQF (or other) level if relevant

Ecole Nationale Superieure de Chimie de Rennes, SOSO team,  http://www.ensc-rennes.fr/themes/recherche-valorisation/cos/

▪  Training in the field of rare carbohydrate

 

EDUCATION AND TRAINING

 

 

2000-2003

Ph.D. thesis

Replace with EQF (or other) level if relevant

University of Chemical Technology and Metallurgy, Department of Organic chemistry; Bulgaria,

title: «Synthesis of fragment analogues of antistasin and ghilantens with anticoagulant activity»,

http://dl.uctm.edu/en/?q=node/155

▪  Training in the field of peptide chemistry and biochemistry

 

EDUCATION AND TRAINING

 

 

1994-1999

Master and engineer degrees in the field of organic synthesis

Replace with EQF (or other) level if relevant

University of Chemical Technology and Metallurgy, Department of Organic chemistry; Bulgaria,

Chemical technology and Engineer chemistry Faculty

▪  Training in the field of organic compounds synthesis

 

 

 

PERSONAL SKILLS

 

 

Mother tongue(s)

Bulgarian

 

 

Other language(s)

UNDERSTANDING

SPEAKING

WRITING

Listening

Reading

Spoken interaction

Spoken production

 

French

B1

B1

B1

B1

B1

 

Diploma. B1.2

English

B1

B1

B1

B1

B1

Russian

B1

B1

A1

A1

B1

 

Replace with name of language certificate. Enter level if known.

 

 

Levels: A1/2: Basic user - B1/2: Independent user - C1/2 Proficient user

Common European Framework of Reference for Languages

 

 

Organisational / managerial skills

  • Ph.D. thesis supervising – 6.
  • Master and bachelor thesis supervising – more than 40

▪        Trainees supervising – more than 30

▪        Head of the Local organizing committee of 33-rd  European Peptide Symposium, Sofia, 2014

▪        Head of Organizing committee of several Bulgarian Peptides Symposiums

 

Job-related skills

▪  good communication skills related to ongoing work with undergraduate and graduate students

▪  good communication skills associated with the continuous participation in various committees and juries

▪  good analytical assessment related to my participation as an evaluator of research projects to National fund for Scientific investigations of Bulgaria

 

Computer skills

  • Working with WINDOWS OFFICE PACKAGE
  • Working with specific chemical software CHEMDRAW, CHEMSKATCH, CHEMWIN
  • Working with i-net applications

 

 

 

Driving licence

▪  Driving license category B

 

ADDITIONAL INFORMATION

 

 

Publications

Presentations

Projects

Conferences

Memberships

                         Citation

                          h-factor

total number 65 (including patents); with i.f. 34, patents and author invention 4, without i.f. 27

Bulgarian Peptide Society –Technical Secretary&Treasurer

20 (including NFSR, SF of UCTM and EU program)

More than 80

European Peptide Society – member

68

5



China

EBTNA Reprasentative in China

Jie Chen

jchen@shu.edu.cn

Professor, Department of Chemical Engineering and Technology
Associate Dean, School of Environmental and Chemical Engineering
Shanghai University, Huanhua Building, No. 333, Nanchen Road, Baoshan, Shanghai 200444, China
Fax: 86-21-66137476, Tel: 86-21-6613-7476 or -7482(O). E-mail: jchen@shu.edu.cn

Education:
1978 – 1982: B.S., Dept. Chem. & Mater. Sci., Shanghia Univeristy of Science and Technology
1990: M.S., Appl. Radiat. Inst., Shanghai University of Science and Technology
2001: Ph.D., Faculty of Sci. and Tech., Kinki University, Japan

Experience:
1982 – 1995: Research Scientist, Shanghai Applied Radiation Institute (SARI), Shanghai University of Science and Technology.
1995 – 2010: Visiting Scientist, Radiation Application Division, Korea Atomic Energy Research Institute (KAERI, 8 months), Korea; Visiting Scholar, Department of Bioengineering, University of Washington (6 months), USA.; Part time visiting scholar, Faculty of Science and Technology, Kinki University, Japan.
2000 – Present: Professor, Department of Chemical Engineering and Technology Shanghai University; Associate director (2002 – 2005).
2005 – Present: Associate Dean, School of Environmental and Chemical Engineering, Executive Director, Center for Intelligent Biomaterials (CIB), Shanghai University.

Publications:
35 Scientific Papers, 3 Books (with one chapter), and 5 Patents

Awards:
“Hydrogel wound dressing”, Second Award of Scientific Advancement, from the PLA of China

Research Interests:
1. Synthesis of Polymeric Biomaterials, (mainly hydrogels, drug carriers).
2. Radiation applications (radiation polymerization, crosslinking and grafting).
3. Application of functional polymers in environmental treatment.



Croatia

EBTNA Reprasentative in Croatia

Anita Slavica

E-mail: aslavica@pbf.hr

Anita Slavica was born in 1970 in Šibenik, Croatia. After degrees in Biotechnology (BSc and MSc) at Faculty of Food Technology and Biotechnology, University of Zagreb, she took PhD in Technical Chemistry at Graz University of Technology, Austria. She habilitated in 2006 in Physiology of Industrial Microorganisms at Department of Biochemical Engineering, the Faculty of Food Technology and Biotechnology, University of Zagreb. Since 2011 she is working as Associate Professor in Laboratory of Biochemical Engineering, Industrial Microbiology, Malting and Brewing Technology at the Department. She is lecturer at „Bioprocess Engineering“ and „Molecular Biotechnology“ MSc degree studies programme and „Biotechnology and Bioprocess Engineering“ PhD programme, researcher in several national/international research projects, supervisor of undergraduate and graduate students, and member of international conferences organizing and scientific comities. Scientific fields of her interest are: mass spectrometry; development and application of analytical methods related to monitoring of sustainable bioprocesses for production of biochemicals; protein expression, purification and characterization; enzyme kinetics; biochemical engineering and industrial microbiology; TT and IPR.

EBTNA Board in Croatia

Anita Slavica (Coordinator)
Bozidar Santek
Srdjan Novak
Predrag Horvat
Mirela Ivancic Santek
Jagoda Suskovic
Ivan Kresimir Svetec
Visnja Gaurina Srcek
Jadranka Frece
Antonio Starcevic

EBTNA Members in Croatia

Vesna Zechner-Krpan
Suncica Beluhan
Tonci Rezic
Vlatka Petravic Tominac
Blazenka Kos
Jasna Beganovic
Visnja Bacun-Druzina
Ksenija Durgo
Ivana Radojcic Redovnikovic
Ksenija Markov
Dušica Vujaklija
Damir Stanzer
Jasna Mrvcic
Vinko Krstanovic
Natalija Velic
Kresimir Gjuracic



Czech Republic

EBTNA Reprasentative in Czech Republic

Stipek Stanislav

stipekst@lf1.cuni.cz

Prof. MUDr. Stanislav Stipek.DrSc. Born 1941, graduated at Faculty of General Medicine in Prague in 1964. Prof. Stipek is member of the Dean Board at the First Faculty of Medicine of the Charles University in Prague. He was in position of the deputy of Dean and Vice-Dean for nine years. As contact person between the Charles University in Prague and the Consortium of the 11 European universities he participated in two Erasmus European Projects (BIOTECHUNTE – Biotechnology University Formation for Enterprises Development, EUROBIOTECH – EUROpean BIOTECHnology,).

He was one from participants of the Project PETRA - PiezoEletric TRansducers and Applications – the network of research training inside the ALFA Programme financed by the European Commission. He is one of the founders of the international educational Medical Faculties Network MEFANET. Regard to research Prof.Stipek is interested in pathobiochemistry of reactive oxygen species, iron toxicity, human antioxidant defense system and cell molecular signaling (142 publications including of 67 research  articles and 2 monographs).Teacher of Medical Biochemistry with 50 years long practice.



Denmark

This page is under construction



Ecuador

EBTNA Represantative in Ecuador

Andrés Izquierdo Romero

Summary:

Andrés Ricardo Izquierdo Romero was born in 1983, in Quito (Ecuador), Biotechnology professional qualified by studies in engineering and environmental sciences. Years of teaching and academic research experience. Specialties: Environmental monitoring, analysis and remediation, ecotoxicology, molecular biology techniques and soil microbiology.

 

Position:

Associate Professor of Microbiology II and Environmental Impact Assessment, Department of Life Sciences and Agriculture, Universidad de las Fuerzas Armadas – ESPE, Sangolqui, Ecuador

arizquierdo@espe.edu.ec  

Mobile phone : + 593984964931, Phone: + 593222290887

 

Education:

2007: Bachelor of Science in Biotechnology Engineering, Escuela Politécnica del Ejército, Sangolqui, Ecuador.

2010: Master of Science in Environmental Contamination and Toxicology, University of Basque Country. Bilbao, Spain.

2013: Master of Science in Advanced Microbiology, Department of Microbiology, Barcelona, Spain

2014: Ph.D in Environmental Microbiology and Biotechnology, Department of Microbiology, Department of Microbiology, Barcelona, Spain

 

Experience:

2014-to date: Associate Professor of Microbiology II and Environmental Impact Assessment, Department of Life Sciences and Agriculture, Universidad de las Fuerzas Armadas – ESPE, Sangolqui, Ecuador

2015-2016: Professor of Management of Hazardous Waste, Master of Environmental Management Systems,   Universidad de las Fuerzas Armadas – ESPE,  Graduate Management Unit, Ecuador.                                                                                                               

2014: Professor of Environmental Management at the School of Military Sciences, Third Military Year, Universidad de las Fuerzas Armadas – ESPE, Escuela Superior Militar Eloy Alfaro, Ecuador.

2014: Professor of  Environmental Biotechnology, Biorremediation, Biosegurity in Faculty of Engineering and Agricultural Sciences (FICA),  Universidad de las Américas UDLA, Ecuador                     

2012-2013: Ph.D Student Visitor, Université Blaise Pascal, Laboratoire Microorganismes: Génome et Environnement , Clermont-Ferrand, France                                         

2008: Professor of Molecular Biology, Escuela Politécnica del Ejercito, Sangolqui, Ecuador.

 

Awards:

Scholarship Award recipient. Army Polytechnic School. 2002 - 2006

Secretariat of Science and Technology Fellowship recipient. 2009-2013

 

Research Interests:

  • Molecular biology techniques and soil microbiology
  • Isolation and identification of extremophiles
  • Bioremediation of hydrocarbons and toxic heavy metals
  • Ecotoxicology
  • Nanotechnology

 



Egypt

EBTNA Represantative in Egypt

Abdelnassar Salah S. İbrahim

Position:

Associate Professor of Microbial Biotechnology, Department of Chemistry of Natural and Microbial Products, Division of Pharmaceutical Industries, National Research Center, El-Buhouth St., Dokki, Cairo 12311, Egypt

nsalah1973@yahoo.com & ashebl@ksu.edu.sa

Education:

1989-1993: BSC of Microbiology/Chemistry, Department of Microbiology, Ain Shams University, Egypt

2000: MSC in Microbiology, Department of Microbiology, Ain Shams University, Cairo, Egypt

2004: .Ph. D in Microbiology, Department of Microbiology, Rostock University, Germany.

Experience:

2010-to date: Associate Professor of Microbial Biotechnology. Department of Chemistry of Natural and Microbial Products, Pharmaceutical Industries, National Research Center, Cairo, Egypt

2005-2010: Assistant Professor of Microbiology, National Research Center, Cairo, Egypt

2006 -01.08.2008: Post doctorate, Department of Biomedical Science, University of Prince Edward Island, Canada

2005-2006: Visiting Scientist at Florida Atlantic University (Florida, USA), Albert-Einstein College of Medicine (New York) and Cornell University (NY, USA)

1995-2000: Researcher assistant, Natural and Microbial Products, Egypt

Publications:

40 Scientific Papers and one translated book (From English to Arabic)

Awards:

King Abdulla Bin Abdulaziz International Award for Translation (2014)

Research Interests:

  1. Isolation and identification of novel enzymes from extremophiles
  2. Bacterial enzymes and cells immobilization
  3. Development Nanobiocatalyst
  4. Bioremediation of toxic heavy metals


Estonia

This page is under construction



Finland

This page is under construction



France

EBTNA Representative in France

Michel Salzet

Since 1998, Professor Michel Salzet is the director of the CNRS then INSERM Laboratory at the University of Lille 1. PRISM is now an European Associated Laboratory with department of Cancer and surgery of Imperial College of London and name, Lancet. Pr. Salzet received his PhD in Biochemistry at the University of Lille 1 in 1993, where he has served as Chair of Immunology since 1997. After his PhD, Pr. Salzet worked as Associate Researcher for one year at the Institute of Neurosciences at Stony Brook University (USA), and was subsequently nominated as Senior Research Scientist at the Beth Israel, Mind Body Institute of Harvard Medical School. He became a member of the Institut Universitaire de France in 1998. Pr. M. Salzet was member from 2009 to 2012 of the core group and the standing committee of the LESC of European Science Foundation and member of management committee of the forward looks in Personalized Medicine for the European Citizen. From 2009 to 2012, he has been nominated at the CNRS as a scientific delegate at the international.  Pr. Salzet is an expert in the field of Neuroimmunology and Proteomic. Salzet has published 274 original articles and 20 book chapters, 4 vulgarization articles and 158 proceedings. He was invited in 84 international conferences and seminars. He is co-founder of IMABIOTECH SAS in 2009 and CLIC-IMAGING platform 2014. He supervised 28 PhD. Pr. Salzet currently has 16 patents. After being the co-director of the doctoral school in Biology and Heath of Lille from 1998 to 2003, he created in 2000, tthe Proteomics Master Degree Program of Lille, which is now recognized as an EU Master. He is presently distinguished Professor (PRECE2) with a chair in immunology since 1997. He received in 1993 the Wicart Hagelstein Medaillon and in 2003 the “Grand Prix des Sciences” by the Science Academy of the Sciences and Letters of Lille. He got the Altran (2014) and MATWIN (2015) innovation prices.



Georgia

EBTNA Reprasentative in Georgia

Prof. Dr. Teo Urushadze

t.urushadze@agruni.edu.ge



Germany

EBTNA Representative in Germany

Brigitte Schmitz

Members
Winrich Breiphol
Hans Eichenger



Greece

EBTNA Representative in Greece

Professor Anargyros Moulas, Ph.D.

Professor Anargyros Moulas is currently Dean of the School of Agriculture and Food Technology and Nutrition of the Technological Education Institute T.E.I. of Thessaly, Greece and head of the laboratory of chemistry and biochemistry. He has a degree in Chemistry (BSc, Aristotle University of Thessaloniki, Greece) and Ph.D. in Biochemistry from the University of Ioannina, Greece. After a post-doc in Biochemistry at the University of Ioannina, he was elected assistant professor at the Technological Education Institute T.E.I. of Larissa, Greece in 1998. In 2000 he was visiting scientist at the Medical College of Virginia, USA and between 2001 and 2002 researcher at the Human Nutrition Laboratory of the USDA, Beltsville MD, USA. In 2005 was elected professor and from 2009 to 2012 he was president of the Department of Nutrition of T.E.I. of Larissa. Between 2012 and 2014 he was visiting researcher at the University of Medicine and Dentistry of New Jersey (currently Rutgers Biomedical), Newark, USA. Has published several papers on fat soluble vitamins and oxidative stress and holds one international patent.

His research interests include health aspects and molecular mechanisms of action of vitamin D and other fat soluble vitamins, functional foods, antioxidants and oxidative stress, controlled release of drugs and chromatographic/spectroscopic methods.



Hungary

EBTNA Representative in Hungary

Details will be added soon.

Deep respect to Gyorgy Keri... Rest in peace

Our condolence over the death of his relatives.



Iceland

EBTNA Reprasentative in Iceland

Reynir Arngrímsson

reynirar@hi.is



India

EBTNA Reprasentative in India

M. N. V. Prasad

prasad_mnv@yahoo.com


M.N.V. Prasad is Professor in the Department of Plant Sciences at the University of Hyderabad, India. He is the author, co-author, editor, or co-editor for eight books (John Wiley and Sons Inc.New York; CRC Press, Boca Raton; Springer-Verlag Heidelberg; Narosa Publishing House, New Delhi; Kluwer Academic Publishers, Dordrecht; Marcel Dekker, New York).  Published 216 articles, 134 research papers in peer reviewed journals and 82 book chapters and conference proceedings in the broad area of  Environmental botany and heavy metal stress in plants. He received the B.Sc. (1973) and M.Sc. (1975) degrees from Andhra University, India, and the Ph.D. degree (1979) in botany from the University of Lucknow, India.

He made outstanding contributions to “Plant-Metal interactions” from molecules to ecosystem. The Ministry of Environment and Forests, Government of India awarded the 2007 Pitamber Pant National Environment Fellowship in recognition of  his  research contribution to the field of Environmental Sciences.



Iran

EBTNA representative in Iran

Mohammad Amin Hejazi

Mohammad Amin Hejazi was born March 27, 1970. He received the B.Sc. and M.Sc. degrees from University of Tabriz and Tarbiat Modaress University, respectively. He made Ph.D on Food Biotechnology at Wageningen University, The Netherlands in 2003. After completing a Postdoctoral period at the same university, he came back to Iran an appointed as the head of Microbial Biotechnology and Biosafety Department at Agricultural Biotechnology Research Institute of Iran (ABRII).

He is Founder of Food Biotechnology Department and Head of Branch for Northwest and West region, ABRII since 2007. He is taking some other responsibilities to promote biotechnology sector at national and regional levels.

He coordinated and implemented several research projects, and published 64 research papers in peer reviewed journals, 7 patents, a book, and 127 conference proceedings and book chapters.

He gives lectures at different universities for postgraduate students. He received several international and national awards for his outstanding achievements in the field of biotechnology.



Ireland

EBTNA Represantative in Ireland

Gary Henehan, Prof. Dr.

Background

Professor Henehan has experience of research and development in academia and in the food, pharmaceutical and biotechnology industries. He lectures in biochemical, toxicological and pharmacological aspects of Food Science and Environmental Health. His research includes collaborative work with the School of Biochemistry and Immunology at Trinity College Dublin and the School of Biotechnology, Dublin City University.

 

Research Interests

  • Professor Henehan has been involved, along with Dr Bourke and Dr Dunne of the School in the development of novel antimicrobial agents from carbohydrate fatty acid conjugates. He is also involved, with Dr Frias of this School in the isolation of novel lipases for applications in organic synthesis.

 

Current Research Projects

  • Isolation of Novel Lipase Enzymes for Applications in Biocatalysis.
  • Role of the Kvβ2 subunit of the Shaker potassium channel. This subunit is involved in the modulation of channel activity in excitable cells.
  • Pathogenesis of Helicobacter pylori-induced gastritis: This organism colonises the gastric mucosa and is thought to cause gastritis by production of toxic aldehydes from dietary precursors. The project is examining pathways of metabolism of toxic aldehydes in H pylori with a view to modelling the exposure of the gastric mucosa to such aldehydes. The project is funded by the Health Research Board.
  • Synthesis of fatty acid sugar esters: The esterification of fatty acids to sugars has led to the production of useful food additives. In particular these compounds have been employed as emulsifiers. More recently it has been found that these compounds have useful antibacterial properties. Current work in this area in collaboration with Dr Seamas Cassidy is examining esterification of fatty acids to lactose. Chemical synthesis using organotin compounds and enzymatic synthesis using immobilised lipases is being investigated.


Israel

EBTNA Reprasentative in Israel

Robert Marks

Email: rsmarks@bgu.ac.il

Prof. Robert S. Marks, (PhD, Weizmann Institute and postdoctorate University of Cambridge) has developed biosensors at the Ben Gurion University, Israel, in the last 15 years resulting in over 75 publications, 20 chapters, 4 granted patents, and founded 4 start-up companies. His work consists in the development of fiber-optic immunosensors (Ebola, Dengue, West Nile, Rift Valley fever viruses, and Hepatitis C, Brucella), and fiber-optic bioreporters biosensors for water monitoring (genotoxicity, cytotoxicity, heavy metals, endocrine disrupting compounds).

Other projects consist in nanotoxicity, development of a reverse genetics cell reporter assay to influenza, a bioreporter panel for the discovery of antibiotics from difficult to grow microorganisms, the discovery of quorum sensor inhibitors as well as epitopes from ebola sudan virus for diagnostics; nanobiotechnology, including nanolithography, nanometer scale structured surfaces for optical enhancement in fluorescence, Raman and infra-red, the creation of tailored nanomaterials including conductive or affinity hydrogels. He has chaired 13 conferences, has given 57 invited and 45 contributed lectures at conferences, 130 posters presentation with colleagues and students, and 130 academic lectures around the world.

He is an adjunct Professor at the University of Maryland and an invited Professor several Universities in, USA (1), Finland (1), France (3) and Italy (1).



Italy

EBTNA Representative in Italy

Prof Mariapia Viola-Magni

General Pathology professor from 1975 at Perugia University and Director of the Institute. She has published 240 paper most in the International Journal: Scientific fields of interest are: cell proliferation in vivo and in vitro; non premitotic DNA synthesis; tumor cell proliferation and oncogene expression; gene expression in hepatocytes during neonatal maturation and liver regeneration; presence of a phospholipidic fraction in hepatocyte chromatin and its metabolism.

She was also Rector delegate for international affairs for the University and participates to many projects In particular she created the School for Technician, the Doctorate in cell and Molecular Pathology, the Consortium of University and Enterprises, TUCEP. From 1976 a network in Biotechnology was created with the support of Europe and two international courses “Job Creation Oriented Biotechnology” and “Biotechnology Medical Application” were created. She was President of European Biotechnology Thematic Network Association (EBTNA) and actually is President of ONLUS research Foundation “Enrico Puccinelli”


Members    
Elisabetta Vecchio    
Fabrizio Bruschi    
Michelle Maffia    
Luigi Magni    
Marco Galeotti    
Marisa Manzano    
Tiziano Gardi   



Japan

This page is under construction



Jordan

EBTNA Represantative in Jordan

Suhair Saleh

Representative: Suhair Saleh

Details will be added soon.



Kazakhstan

EBTNA Reprasentative in Kazakhstan

Alma Kokhmetova

gen_kalma@mail.ru

Present Position:
Head of Lab. Genetics & Breeding of the Institute of Plant Biology and Biotechnology of National Biotechnological Center Republic of Kazakhstan

Education:
Doctor of Biological Sciences (D.Sci.). 2005. Genetics. Al-Farabi Kazakh National University, Faculty of Biology, Almaty, Kazakhstan.
PhD. 1991. Plant Breeding, Kazakh Institute of Agriculture, Almalybak, Kazakhstan.
MSc, 1983. Agronomy Kazakh Agricultural Institute, Almaty, Kazakhstan.

Period of study abroad:
• 01.12.1995-31.01. 1996. Israel, study program “Biological and Physical aspects of Crop Production in arid zones”. Certificate of attendance.
• 08-22.02.1997. Iowa State University and Kansas State University, USA, Cochran Fellowship Program “Seed&Seed Technology”. Certificate of attendance.
• 07. 07. 1997-26.07. 1997, Sharvas, Hungary, Darvin Initiative training course in Plant conservation. Certificate of attendance.
• 02.11.1998-11.12.1998. 4th International Programme on Strategies for Sustainable Agriculture and Rural Development, National Institute of Rural Development, Hyderabad, India. Certificate of attendance.
• 14.03-25.06.1999. The Netherlands, Wageningen Agricultural University, International Course on Applied Plant Breeding. Fellowship program. Certificate  with credits.
• 10.05. – 21.05. 1999. The third Int. Course on Plant Variety Protection, Wageningen, The Netherlands. Certificate of attendance.
• 28.03.2006-30.05.2006. USA, Washington State University, Pullman, WA. Dept. of Plant Pathology. Training under ICAR project: «Marker Assisted Selection and Wheat Breeding».
• 10.12.2009-24.12.2009. ICARDA, 2009 (Aleppo, Syria). Specialized Training Course on Seedling Assessment of Wheat Rusts held. Certificate of attendance.



Latvia

EBTNA Reprasentative in Latvia

Anna Zajakina

anna@biomed.lu.lv

1. NAME: Anna Zajakina MAILING ADDRESS: Cell Biology Department, Biomedical Research and Study Centre (BMC), Ratsupites Str., 1, Riga LV-1067, Latvia. PHONE: 371 29150597, FAX NUMBER: 371 67442407, E-mail: Anna@biomed.lu.lv

2. AGE. DATE AND PLACE OF BIRTH: 37 years; October 14, 1974. Riga.

3. EDUCATION: 2005: Research Doctoral degree/PhD in molecular biology, PhD thesis “Reconstruction of hepatitis B virus in vivo”, University of Latvia. Supervisors – Dr.Habil Biol. T. Kozlovska, Prof. Dr. P. Pumpens. Opponents - Prof. V. Baumanis (Latvia), Prof. W. H. Gerlich (Germany); Prof. K. Sasnauskas (Lithuania). 1998: Master Diploma - “Development of recombinant RNA packaging vectors on the basis of bacteriophage Qβ”, University of Latvia, major disciplines - molecular biology & biochemistry. Supervisor - Dr.habil.biol. T. Kozlovska.

International education: 2005, June: FEBS fellowship “Advanced light microscopy”, Semmering, Austria. 2004, March: EuroLabCourse fellowship „Vectorology in gene therapy”, Paris, France. 2002, October: EMBO practical course “Cell Biology of Virus Infection”, Heidelberg, Germany. 2001, September: FEBS fellowship „International Summer School on Protein Biology: From Synthesis to Function and Disease”, Spetses, Greece. 1997, March-May: Sweden and Latvian cooperation fellowship “Elective course in Pharmacology, with special reference to target proteins for drug development”, Uppsala, Sweden. 1997, June: FEBS fellowship “Basic and specialized techniques in cell biology”, Aarhus, Denmark. 1996, June: University of Rostock fellowship „International Hanseatic student days: Advanced methods in experimental medicine”, Rostock, Germany.
Additional education: 2010-present Economics and Management faculty, University of Latvia, major discipline – project management, accounting (third year student).

4. Employment history: 09/2008-present: senior researcher, group leader, BMC, Riga, Latvia; 10/2005-12/2008: lecturer, University of Latvia, Biology faculty; 12/2004-09/2008: researcher, BMC, Riga, Latvia; 05/2003-12/2004: career break, maternity leave; 09/1999-05/2003: scientific assistant, BMC, Riga, Latvia 05/1998-09/1999: career break, maternity leave; 07/1994-05/1998: assistant, undergraduate student, BMC, Riga, Latvia International experience: 2009, October-December: scientific work in Latvia/France cooperation project „OSMOZE” „Intracellular transport of Hepatitis B virus core antigen”, University of Bordo, France. 2008, November-December: scientific work in Latvia/France cooperation project „OSMOZE” „Analysing the intracytosolic transport of chimeric hepatitis B viruscapsids exposing domains of the HIV integrase”, University of Bordo, France. 1997, June-September: scientific work in project “Cytokine pathways in hematopoietic cells”, University of Rostock, Germany.

5. Latvian and international projects: „Elaboration of delivery system for DNA, RNA, protein, peptide, and smal molecule medical preparations”, State Research Programme (2010-2014) main participant, scientific...
“Novel model of HBV infection and a technology for antiviral agent evaluation”, 2011-2013 European Regional Development Fund (ERDF) 2010/0233/2DP/2.1.1.1.0/10/APIA /VIAA/075
„Modelling of HBV replication” (ERDF, 2006-2008). Main participant. Nr. VPD1/ERAF/CFLA/05/APK/2.5.1./000018/008; „Reconstruction of HBV particles in vivo”. The ESF and Ministry of Education and Science grant for young scientists (2005-2008). Head of the project. VPD1/ESF/PIAA/04/NP/3.2. 3.1/0002/0007; 3630 „Analysing the intracytosolic transport of chimeric heptitis B viruscapsids exposing domains of the HIV integrase „ (2007-2008) OSMOZE project. Participant. National coordinator. “Combined immune and gene therapy for chronic viral hepatitis”, EU project Contract No QLK2-Ct-2000-01476. „A therapeutic DNA vaccine against chronic hepatitis B virus infections delivered by in vivo electroporation”. The Swedish Institute Project (2004-2007). „Artificial chimeric proteins as diagnostic, vaccine, and gene therapy carriers”. (2004-2007) QoL Project, Marie Curie Training Site; „Construction of HBV/HCV replication models for the design and screening of putative antiviral drugs”. (2003-2005) Taiho Project: „Hepatitis B virus assembly, structure and entry into new host cells”. (1999-2001) KIRT programme.

6. MENTORING/TUTORING ACTIVITIES Doctoral thesis supervision (in progress): „Modelling of Hepatitis B virus (HBV) infection in differentiated stem cells”, Diana Legzdiņa PhD student, BMC; „HBV genome replication in vivo using alphaviral vectors”, Vladimirs Hutornojs PhD student, BMC; „Alphaviral vectors as gene delivery tools for cancer treatment”, Jeļena Vasiļevska PhD student, BMC;

7. AWARDS 08/2010: oral presentation prize, EMBO Advanced symposium, „Recombinant Semliki Forest Virus distribution in mice”, authors: A.Zajakina, J.Vasilevska, D.Skrastina, T.Kozlovska.  Kuopio, Finland. 05/2005: L’ORÉAL-UNESCO & Latvian Academy of Sciences award “For Women in Science”. 12/1998: : Annual prize of Latvian Academy of Science and joint-stock company "Grindeks” for young scientists, the best Msc. diploma thesis „ Development of recombinant RNA incapsidation system on the basis of bacteriophage Qβ”. Supervisor Dr. habi. biol.T. Kozlovska.

8. Profeccional activities: evaluation expert of FP7-PEOPLE-2012-IEF-IIF-IOF – LIFE panel proposals; national expert of Latvian Academy of Sciences;

Members
Karina Spunde



Lithuania

EBTNA Represantative in Lithuania

Daumantas Matulis

Daumantas Matulis

Head of Laboratory of Biothermodynamics and Drug Design

Institute of Biotechnology

Vilnius university

Graiciuno 8

LT-02241, Vilnius

Tel. +370-5-269-1884

matulis@ibt.lt

daumantas.matulis@bti.vu.lt

http://www.ibt.lt

 

Education

Year of completion

Institution

Degree

2001

University of Minnesota

Biophysics, postdoctoral associate

1998

University of Minnesota

Biochemistry and biophysics, Ph.D.

1993

Vilnius University

Biochemistry, 5-year diploma (BS/MS)

1992 Summer

University of Oslo

School of Environmental Protection

 

Professional experience

Period

Institution

Position

2005-present

Institute of Biotechnology

Head of Laboratory

2001-2005

3-Dimensional Pharmaceuticals (acquired by Johnson&Johnson);

Johnson&Johnson, Pharmaceutical Research and Development

Scientist

1998-2001

University of Minnesota

Postdoctoral associate

1994-1998

University of Minnesota

Research Assistant

1993-1994

Institute of Biochemistry

Junior scientist

 

Teaching

  1. “Molecular Biophysics” course for Bachelor students, Faculty of Natural Sciences, VilniusUniversity, 2011- present.
  2. “Biophysical Chemistry of Proteins” course for the Master students, Faculty of Natural Sciences, VilniusUniversity, 2005- present.
  3. “Structure, Folding and Dynamics of Proteins and Their Complexes”, FEBS course, Budapest, Hungary, 2009.
  4. Life Sciences Summer Undergraduate Research Program, University of Minnesota, 1999 – 2000.
  5. Biochemistry Laboratory course, University of Minnesota, 1997 – 1999.
  6. “Biophysical Chemistry of Proteins”, textbook for the Master students, Vilnius University.

 

Awards, achievements

  1. Lithuanian National Science award 2012. 
  2. Life Science Baltics Startup Session, Lithuania, Vilnius. 2012 (second place).
  3. The Best Poster award in the Conference “Biochemija ir biofizika Vilniaus universitete”, Lithuania, Vilnius. 2012 (third place).
  4. The Best Poster award in the Conference „XVII International Society of Biological Calorimetry (ISBC) Conference“, Germany, Leipzig. 2012 (second place).
  5. The Best Poster award in the Conference “ESBES+ISPPP+ISB“, Italy. 2010.
  6. ScanBalt Bridge Baltic Sea Region Award, Sweden. 2009.
  7. Public advisor to the President of Lithuania for the issues of emigration and repatriation, 2007-2009.
  8. Selected as Lithuanian representative young scientist in the book “Portraits of Science. Scientists of Tomorrow” by European Federation of Pharmaceutical Industries and Associations, 2008.
  9. Award “Direction-Home” given to Lithuanian scientist selected by an independent Swedish-Lithuanian scientific council, by “Telia Sonera” Inc., Sweden, 2007.
  10. Robert Jenness Award by University of Minnesota Department of Biochemistry, Molecular Biology, and Biophysics for the best postdoctoral associate in 2000.
  11. National high school Olympic competition in chemistry, third place, 1988.

 

Scientific Publications

  1. Capkauskaite, E., Zubriene, A., Smirnov, A., Torresan, J., Kisonaite, M., Kazokaite, J., Gylyte, J., Michailoviene, V., Jogaite, V., Manakova, E., Grazulis, S., Tumkevicius, S., Matulis, D. 2013. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII. Biorg. Med. Chem. 21: 6937-6947.
  2. Petrauskas, V., Gylyte, J., Toleikis, Z., Cimmperman, P., Matulis, D. 2013. Volume of Hsp90 ligand binding and the unfolding phase diagram as a function of pressure and temperature. Eur. Biophys. J. 42: 355-362.
  3. Dudutiene, V. Zubriene, A., Smirnov, A., Gylyte, J., Timm, D., Manakova, E., Grazulis, S., Matulis, D. 2013. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. Bioorg. Med. Chem. 21: 2093-2106.
  4. Jogaite, V., Zubriene, A., Michailoviene, V., Gylyte, J., Morkunaite, V., Matulis, D. 2013. Characterization of Human Carbonic Anhydrase XII Stability and Inhibitor Binding. Bioorg. Med. Chem. 21: 1431-1436.
  1. Pirrie, L., McCarthy, A. R., Major, L., Morkunaite, V., Zubriene, A., Matulis, D., Lain, S., Lebl, T., Westwood, N. J. 2012. Discovery and Validation of SIRT2 Inhibitors Based on Tenovin-6: Use of a H-NMR Method to Assess Deacetylase Activity. Molecules. 17: 12206-12224.
  2. Sharp, S. Y., Roe, S. M., Kazlauskas, E., Cikotiene, I., Workman, P., Matulis, D., Prodromou, C. 2012. Co-Crystalization and In Vitro Biological Characterization of 5-Aryl-4-(5-Substituted-2-4- Dihydroxyphenyl)-1,2,3- Thiadiazole Hsp90 Inhibitors. Plos One. 7(5): e44642.
  3. Labanauskas, L., Dudutiene, V., Urbelis, G., Sarlauskas, J., Sudzius, J., Matulis, D., Striela, R., Zilinskas, A. 2012. Synthesis of substituted 2λ 4 δ 2-[1,2,3]thiadiazolo[3,4-c]benzimid-azoles and 2λ 4 δ 2-[1,2,3,5]thiatriazolo[3,4-c]benzimidazoles. Arkivoc. 8: 17-26.
  4. Kazlauskas, E., Petrikaite, V., Michailoviene, V., Revuckiene, J., Matuliene, J., Grinius, L., Matulis, D. 2012. Thermodynamics of Aryl-dihydroxyphenyl-thiadiazole Binding to Human Hsp90. Plos One. 7(5): e36899.
  5. Toleikis, Z., Cimmperman, P., Petrauskas, V., Matulis, D. 2012. Serum albumin ligand binding volumes using high pressure denaturation. Journal of Chemical Thermodynamics. 52: 24-29.
  6. Toleikis, Z., Cimmperman, P., Petrauskas, V. and Matulis, D. 2011. Determination of the volume changes induced by ligand binding to heat shock protein 90 using high-pressure denaturation. Analytical Biochemistry. 413: 171-178.
  7. Zubriene A., Kazlauskas E., Baranauskiene L., Petrauskas V., Matulis D. 2011. Isothermal Titration Calorimetry and Thermal Shift Assay in Drug Design. European Pharmaceutical Review. 16 (3): 56-59.
  8. Cimmperman, P and Matulis, D. 2011. Protein Thermal Denaturation Measurements via a Fluorescent Dye. Invited review to the book: RSC Biomolecular Sciences No. 22. Biophysical Approaches Determining Ligand Binding to Biomolecular Targets: Detection, Measurement and Modelling. Edited by A. Podjarny, A. Dejaegere, and B. Kieffer. Royal Society of Chemistry. Chapter 8.
  9. Petrikaite, V., Matulis, D. Thermodynamics of Natural and Synthetic Inhibitor Binding to Human Hsp90. In: "Application of Thermodynamics to Biological and Materials Science". Ed. Mizutani Tadashi, 2011, 77-92.
  10. Petrikaite, V., Matulis, D. 2011. Natural and synthetic inhibitors binding to human Hsp90 and their clinical application. Medicina (Kaunas). 47 (8): 413:420.
  11. Petrikaite, V. and Matulis, D. 2010. Thermodynamics of Natural and Synthetic Inhibitor Binding to Human Hsp90. Thermodynamics. 77- 92.
  12. Capkauskaite, E., Baranauskiene, L., Golovenko, D., Manakova, L., Grazulis, S., Tumkevicius, S., and Matulis, D. 2010. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII. Bioorg. Med. Chem. 18: 7357-64.
  13. Sudzius, J., Baranauskiene, L., Golovenko, D., Matuliene, J., Michailoviene, V., Torresan, J., Jachno, J., Sukackaite, R., Manakova, L., Grazulis, S., Tumkevicius, S., and Matulis, D. 2010. 4-[N-(Substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII. Bioorg. Med. Chem. 18: 7413-21.
  14. Baranauskiene, L., Hilvo, M., Matuliene, J., Golovenko, D., Manakova, E., Dudutiene, V.,  Michailoviene, V., Torresan, J., Jachno, J., Parkkila, S., Maresca, A., Supuran, C. T., Grazulis, S., and Matulis, D. 2010. Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides, J. Enz. Inhib. Med. Chem., 25(6): 863-70.
  15. Zurawska, A., Urbanski, J., Matuliene, J., Baraniak, J., Klejman, M. P., Filipek, S., Matulis, D. and Bieganowski, P. 2010. Mutations that increase both Hsp90 ATPase activity in vitro and Hsp90 drug resistance in vivo. BBA – Molec. Cell Res. 1803(5): 575-583.
  16. Labanauskas, L., Dudutiene, V., Matulis, D., Urbelis, G. 2009. Synthesis of a new heterocyclic system: 3 phenylbenzimidazo[1,2-c]-[1,2,3]selenadiazole. Chem. Heterocycl. Comp. No. 9: 1153-1154.
  17. Ugele, M., Sasse, F., Knapp, S., Fedorov, O., Zubriene, A., Matulis, D., Maier, M.E. 2009. Propionate Analogues of Zearalenone Bind to Hsp90. Chembiochem. 4;10(13): 2203-12.
  18. Baranauskiene, L., Petrikaite, V., Matuliene, J., Matulis, D. 2009. Titration Calorimetry Standards and the Precision of Isothermal Titration Calorimetry Data. Int. J. Mol. Sci. 10: 2752-2762.
  19. Zubriene, A., Matuliene, J., Baranauskiene, L., Jachno, J., Torresan, J., Michailoviene, V., Cimmperman, P., Matulis, D. 2009. Measurement of Nanomolar Dissociation Constants by Titration Calorimetry and Thermal Shift Assay – Radicicol Binding to Hsp90 and Ethoxzolamide Binding to CAII. Int. J. Mol. Sci. 10: 2662-2680.
  20. Cikotiene, I., Kazlauskas, E., Matuliene, J., Michailoviene, V., Torresan, J., Jachno, J., Matulis, D. 2009. 5-Aryl-4-(5-substituted-2,4- dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone. Bioorg Med Chem Lett. 19: 1089-1092.
  21. Hilvo, M., Baranauskiene, L., Salzano, A.M., Scaloni, A., Matulis, D., Innocenti, A., Scozzafava, A., Monti, S.M., Di Fiore, A., De Simone, G.,  Lindfors, M., Jänis, J., Valjakka, J., Pastoreková, S., Pastorek, J., Kulomaa, M.S., Nordlund, H.R., Supuran, C.T., Parkkila, S. 2008 Biochemical characterization of CA IX: one of the most active carbonic anhydrase isozymes. J Biol Chem. 283: 27799-27809.
  22. Cimmperman, P., Baranauskiene, L., Jachimoviciute, S., Jachno, J., Torresan, J., Michailoviene, V., Matuliene, J., Sereikaite, J., Bumelis, V., Matulis, D. 2008. A Quantitative Model of Thermal Stabilization and Destabilization of Proteins by Ligands. Biophys. J. 95: 3222-3231.
  23. Baranauskiene, L., Matuliene, J., Matulis, D. 2008. Determination of the thermodynamics of carbonic anhydrase acid-unfolding by titration calorimetry. J. Biochem. Biophys. Meth. 70: 1043­-1047.
  24. Dudutiene, V., Baranauskiene, L., Matulis, D., 2007. Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase. Bioorg Med Chem Lett. 17, 3335-3338.
  25. Matulis, D., Kranz, J., Salemme, F.R., and Todd, M.J. 2005. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry. 44: 5258-66.
  26. Matulis, D., Lovrien, R. 2005. Assays for Total Protein. Current Protocols in Protein Science: 3.4.1-3.4.4. Republished updated version.
  27. Matulis, D. and Todd, M. 2004. Thermodynamics – structure correlations of sulfonamide inhibitor binding to carbonic anhydrase. Biocalorimetry 2, eds. Ladbury, J.E. and Doyle, M.L. Wiley. 107-132.
  28. Matulis, D., Rouzina, I. and Bloomfield, V. 2002. Thermodynamics of cationic lipid binding to DNA and DNA condensation: Roles of electrostatics and hydrophobicity. J. Am. Chem. Soc. 124: 7331-7342.
  29. Lovrien, R., Wu, C., and Matulis, D. 2000. Ligand - protein coprecipitative isolation by matrix stacking and entanglement. Sep. Sci. Technol. 35(11): 1795-1811.
  30. Matulis, D., Rouzina, I., and Bloomfield, V. 2000. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. J. Mol. Biol. 296: 1053-1063.
  31. Matulis, D., Baumann, C., Bloomfield, V., and Lovrien, R. 1999. 1-Anilino-8-naphthalene sulfonate as a protein conformational tightening agent. Biopol. 49: 451-458.
  32. Matulis, D., Wu, C., Pham, T., Guy, C., and, Lovrien, R. 1999. Protection of enzymes by aromatic sulfonates from inactivation by acid and elevated temperatures. J. Molec. Catalysis B: Enzymatic. 7: 21-36.
  33. Lovrien, R. and Matulis, D. 1998. Determination of total protein. Current Protocols in Pharmacology. John Wiley and Sons. Appendix.
  34. Matulis, D., and Lovrien, R. 1998. 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation. Biophys. J. 74: 422-429.
  35. Wu, C., Lovrien, R. and Matulis, D. 1998. Lectin coprecipitative isolation from crudes by little rock orange ligand. Analyt. Biochem. 257: 33-39.
  36. Rubikas, J. and Matulis, D. 1998. Nickel resistance in Escherichia coli V38 isolated from city sewage sludge. Ekologija. 9: 24-28.3.
  37. Rubikas, J., and Matulis, D. 1998. Nickel ion efflux is the main mechanism of resistance in Escherichia coli V38. Ekologija. 9: 29-32.
  38. Matulis, D., Lovrien, R. 1997. Selective Precipitation of Proteins. Current Protocols in Protein Science: 4.5.1-4.5.36.
  39. Rubikas, J., Matulis, D., Leipus, A., and Urbaitienė, D. 1997. Nickel resistance in Escherichia Coli V38 is dependent on the concentration used for induction. FEMS Microbiol. Lett. 155: 193-198.
  40. Matulis, D., Richardson, T. and Lovrien, R. 1996. Coprecipitation of proteins with matrix ligands: scaleable protein isolation. J. Molec. Recogn. 9: 433-443.
  41. Matulis, D., Lovrien, R. 1995. Assays for Total Protein. Current Protocols in Protein Science: 3.4.1-3.4.4.
  1. Giessrigl, B., Krieger, S., Rosner, M., Huttary, N., Saiko, Ph., Alami, M., Messaoudi, S., Peyrat, J. F., Maciuk, A., Gollinger, M., Kopf, S., Kazlauskas, E., Mazal, P., Szekeres, T., Hengstschlager, M., Matulis, D., Jager, W., Krupitza, G. 2012. Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle Q1 attenuation in pancreatic carcinoma cells. Human Molecular Genetics. 21: 4615-4627.
  1. Capkauskaite, E., Zubriene , A., Baranauskiene, L., Tamulaitiene, G., Manakova, L., Kairys,  V., Grazulis, S., Tumkevicius, S., Matulis, D. 2012. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases. Eur. J. Med. Chem. 51: 259-270.
  2. Norvaisas, P., Petrauskas, V., and Matulis, D. 2012. Thermodynamics of Cationic and Anionic Surfactant Interaction. J. Phys. Chem. B. 116: 2138-2144.
  3. Baranauskiene, L., Matulis, D.  2012. Intrinsic thermodynamics of ethoxzolamide inhibitor binding to human carbonic anhydrase XIII. BMC Biophysics. 5:12 2046-1682
  1. Zubriene, A., Gutkowska, M., Matuliene, J., Chaleckis, R., Michailoviene, V., Voroncova, A., Venclovas, C., Zylicz, A., Zylicz, M., and Matulis, D. 2010. Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms. Biophys. Chem. 152: 153-163.
  2. Rink, C., Sasse, F., Zubriene, A., Matulis, D. and Maier, M. E. 2010. Probing the Influence of an Allylic Methyl Group in Zearalenone Analogues on Binding to Hsp90. Chemistry. A European Journal. 16(48): 14469-78.
  1. Matulis, D. 2001. Thermodynamics of the hydrophobic effect. III. Condensation and aggregation of alkanes, alcohols, and alkylamines. Biophys. Chem. 93: 67-82.
  2. Matulis, D., and Bloomfield, V. 2001. Thermodynamics of the hydrophobic effect. II. Calorimetric measurement of enthalpy, entropy, and heat capacity of aggregation of alkylamines and long aliphatic chains. Biophys. Chem. 93: 53-65.
  3. Matulis, D., and Bloomfield, V. 2001. Thermodynamics of the hydrophobic effect. I. Coupling of aggregation and pKa shifts in solutions of aliphatic amines. Biophys. Chem. 93: 37-51.

 

Patents

  1. European Patent No. 2054420.  “Benzimidazo[1,2-C][1,2,3]Thiadiazol-7-Sulfonamides as Inhibitors of Carbonic Anhydrase and the Intermediates for Production Thereof”. Application submited in 2007, patent registered on 2011 06 22
  2. European Patent No. 2268626. “5-Aryl-4-(5-Substituted 2,4-Dihydroxyphenyl)- 1,2,3 Thiadiazoles as Inhibitors of Hsp90 Chaperone and the Intermediates for Production Thereof”. Application submited in 2008, patent registered on 2012 02 01

 

Patent Application

  1. Matulis D., Dudutiene V., Zubriene A.

Fluorinated benzenesulfonamides as inhibitors of Carbonic Anhydrase. PCT/LT2012/000007. 2012-10-30

 

Other important academic activities

  1. Written about 15 articles on the subjects of scientific reform, the popularity of science in society, and the support for repatriating scientists.
  2. Participated in several TV programs and radio shows on science popularity and administrative reforms.
  3. Member of several work groups at the Ministry of Economy and the Ministry of Science and Education; discussions and preparation of legal documents in science administration.
  4. Member of professional societies – American Chemical Society, Biophysical Society, an expert of the ScanBalt projects, mapping of Baltic biotechnology, discussions on  international collaboration of biotechnologists. An expert to the EU FP7 “Health” program committee in Brussels.
  5. Member of the ScanBalt task force for the implementation of the EU Baltic Sea strategy

 

Conference organization

  1. „COST TD0905“, 2013 10 30-31, Vilnius, Lithuania.
  2. Co-Chairman of CEEC-TAC2 2nd Central and Eastern European Conference on Thermal Analysis and Calorimetry, 2013 08 27-30, Vilnius, Lithuania.
  3. Local Chair and Member of ScanBalt Scientific Advisory Board of the ScanBalt Forum and ScanBalt Biomaterials Days, 2008 09 24-26, Vilnius, Lithuania.

 

Invited talks at international conferences and organizations

1.      Matulis D. “Biophysical assays of inhibitor binding to selected CA isozymes”. 2nd CA satellite meeting, Naples, Italy. 2013 10 23-25.
2.      Matulis D. “Novel inhibitors of Carbonic Anhydrase IX, an Anticancer Target“.Lithuanian Trade Mission to Boston (and Washington), Boston, USA. 2013 06 16-25.
3.      Matulis D. “Intrinsic thermodynamics – structure correlations of anticancer drug lead binding to target proteins”. “CEEC-TAC2”, Vilnius, Lithuania. 2013 08 27-30.
4.      Matulis D. Intrinsic thermodynamics - structure correlations of anticancer drug lead binding to target proteins.„ 20th Biennial Meeting of the International Society for Molecular Recognition“, Vienna, Austria. 2013 06 26-29. 
5.      Matulis D. Drug Design: Intrinsic Energetics – Structure Correlations,  ITC, TF, Activity, X-ray. „Biophysical Society 57th Annual Meeting”, Philadelphia, USA. 2013 01 31-02 14.
6.      Matulis D. Design, synthesis, binding, crystallography, and docking of [(2-pyrimidinylthio)acetyl] benzenesulfonamides as inhibitors of human carbonic anhydrases. „COST0804“, Salerno, Italy. 2012 11 03-07.
7.      Matulis D. Overview of Lithuanian Pharmaceutical Industry. „Life Sciences Baltics Conference“. Vilnius, Lithuania. 2012 09 12-14.
8.      Matulis D.  Thermodynamics Of Inhibitor Binding To Recombinant Human Carbonic Anhydrases (CA) VI and XII. „Future in Chemistry and Biology for Epigenetics training school“. Poitiers, France. 2012 07 09-12
9.      Matulis, D. Structural biothermodynamics of inhibitor binding to human recombinant carbonic anhydrases and Hsp90.  Presented at the “66th Calorimetry Conference”. Honolulu, USA. 2011 06 14.
10.  Matulis, D. Carbonic anhydrase inhibitors as anticancer agents. Molėtai, Lithuania. 2010 06 16.
  1. Matulis, D. Structural biothermodynamics and the search for drug-like compounds. Plenary lecture given at the Institute of Theoretical Physics and Astronomy of Vilnius university, Molėtai Astronomical Observatory, Molėtai, Lithuania. 2010 07 31.
  2. Matulis, D. Structural biothermodynamics and the search for drug-like compounds. Plenary lecture given at the Conference of Organic Synthesis, Kaunas University of Technology, Kaunas, Lithuania. 2009 04 22.
  3. Matulis, D. Carbonic anhydrase and Hsp90 inhibitor binding measurements by TSA, ITC, and X-ray crystallography. Instruct meeting. Budapest, Hungary. 2009 03 30.
  4. Matulis, D. Characterization of carbonic anhydrases and determination of inhibitor binding by thermal shift assay. Invited by Prof. Seppo Parkkila, Institute of Medical Technology / University of Tampere, Biokatu 6, 33520 Tampere, Finland. 2007 11 19.
  5. Matulis, D. Characterization of carbonic anhydrases and determination of inhibitor binding by thermal shift assay. Invited by Prof. Claudiu Supuran, Universita Degli Studi Di Firenze, Dipartimento Di Chimica, Italy. 2007 11 23.
  6. Matulis, D. Human Hsp90 stability and radicicol binding by thermal shift assay. Invited by Prof. Maciej Zylicz, International Institute of Molecular and Cell Biology in Warshaw, Poland. 2006 12 15.
  7. Matulis, D., and Todd, M. Thermodynamics of sulfonamide inhibitor binding to carbonic anhydrase using titration calorimetry: an interesting effect of protein, ligand, and buffer protonation. Presented at the 2003 Current Trends in Microcalorimetry, Boston, USA. 2003 07.
  8. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. Presented at the Nucleic Acid Interest Group, University of Minnesota. 1999 11.
  9. Matulis, D. Using isothermal titration calorimetry to evaluate the energetics of intermolecular interactions. Presented at the Nucleic Acid Interest Group, University of Minnesota. 1998 03.

 

Talks given at conferences and meetings

1.      Matulis D. „ExCo meeting“. 2013 06 03 – 04 . Rostock, Germany.
2.      Matulis D. “The Pitfalls of Drug Lead IC 50 and Binding Measurements to Target Proteins”. „COST CM0804“. 2013 05 06-09, Izmir, Turkey.
3.      Matulis, D., Budvytyte, R., Cerniauskaite, D. 11th ScanBalt Forum. 2012 11 20 – 23. Tampere, Finland.
4.      Matulis, D., Budvytyte, R. „ExCo meeting“. 2012 08 28. Copenhagen, Denmark.
5.      Matulis, D. Thiophene Sulfonamides as Carbonic Anhydrase Inhibitors by Titration Calorimetry and Thermal Shift Assay. COST TD 0905, Latvia, Riga. 2012 06 26-28. 
6.      Matulis, D. Anticancer activity of ICPD inhibitors of Hsp90 on human tumor cell lines and in murine tumor allografts. „COST0804“, Bucuresti, Romania. 2012 05 20-24.
7.      Blank, W., Matulis, D., Frank, P. ScanBalt Health Region – Setting the Stage for Cross-Sectorial Innovation in Health and Life Sciences. What is in for the regions? Baltic Development Forum. 2011 10 25 – 27. Gdansk, Poland.
8.      Matulis, D., Grinius, L., Revuckiene, J., Budvytyte, R., Cerniauskaite, D. „BSHR HealthPort“ project meeting. 10th ScanBalt Forum. 2011 09 21 – 24. Heringsdorf, Germany.
  1. Matulis, D. Structural biothermodynamics of inhibitor binding to human recombinant carbonic anhydrases. “FEBS satellite CA meeting”. Montecatini, Italy. 2011 06 22-24.  
  2. Zubrienė, A., Kazlauskas E., Baranauskienė, L., Petrauskas, V., Matulis, D. Towards the intrinsic lead binding thermodynamics.  COST TD 0905. Split, Croatia. 2011 04 28-05 01.
  3. Matulis, D. Determination of the Volume Changes Induced by Ligand Binding to Hsp90 Using High Pressure Denaturation. Biophysical Society 55th Annual Meeting. Baltimore, USA. 2011 03 05-09.
  4. Matulis, D. Structural biothermodynamics of inhibitor binding to human recombinant carbonic anhydrases and Hsp90. Johnson & Johnson. USA. 2011 03 10.
  5. Toleikis,  Z., Cimmperman, P., and Matulis, D. The Volumes of Ligand Binding to Hsp90 by High Pressure Denaturation. The 6th International Conference on High Pressure Bioscience and Biotechnology (HPBB2010). Munich, Germany. 2010 08 28-09 01.
  6. Zubriene, A., Matulis, D. Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms. ESBES+ISPPP+ISB. Bologna, Italy. 2010 09 05-08.
  7. Zubriene, A., Maier, E.M., Sasse, F., Kazlauskas, E., Toleikis, Z., Chaleckis, R., Michaoloviene, V., Petrikaite, V., Grinius, L., Matuliene, J., Matulis, D. Radicicol, a natural compound and an efficient inhibitor of Hsp90, as a lead for anticancer drug design. COST CM0804, “Natural Products as Drug and Leads to Drugs”. Crete, Greece. 2010 10 12-15.
  8. Zubriene, A., Baranauskiene, L., Kazlauskas, E., Toleikis, Z., Chaleckis, R., Michailoviene, V., Petrikaite, V., Capkauskaite, E., Dudutiene, V., Matuliene, J., Matulis, D. Drug Binding Energetics by Titration Calorimetry, Thermal and Pressure Shift Assay. COST Action TD09/05 Epigenetics - Bench to Bedside. Brno, Czechia. 2010 11 22-25.
  9. Baranauskiene, L., Kazlauskas, E., Cikotiene, I., Matuliene, J., Zubiene, A., Jachno, J., Torresan, J., Michailoviene, V., Cimmperman, P., Grazulis, S., and Matulis D. Carbonic anhydrase and Hsp90 inhibitor binding measurements by thermal shift assay, titration calorimetry, and x-ray crystallography. INSTRUCT meeting. Budapest, Hungary. 2009 03 29-31.
  10. Baranauskienė, L., Sūdžius, J., Michailovienė, V.,  Matulienė, J., Tumkevičius, S., Matulis, D. Carbonic anhydrase ligand binding by thermal shift assay and titration calorimetry. The 8-th International Conference on the Carbonic Anhydrases. Florence, Italy. 2009 09 16-19.
  11. Cimmperman, P., Zubriene, A., Baranauskiene, L., Kazlauskas, E., Matuliene, J., and Matulis, D. Determination of protein-ligand binding thermodynamics by thermal shift assay. European Biophysics Congress Genova. Genova, Italy .2009 07 11-15.
  12. Petrikaitė, V., and Matulis, D. Thermal Shift Assay and Titration Calorimetry for Protein-Ligand Interactions. COST CM0804 Conference “Chemical Biology with Natural Products. Siena, Italy. 2009 12 3-5.
  13. Kazlauskas, E., Cikotiene, I., Matuliene, J., Zubriene, A., Jachno, J., Torresan, J., Michailoviene, V., Matulis, D. Resorcinol class Hsp90 inhibitor binding thermodynamics and the effect on cancerous cells. The 4th International Conference on the Hsp90 Chaperone Machine. Bavaria, Germany. 2008 10 2‑6.
  14. Baranauskiene, L., Dudutiene, V., Matulis, D. Benzimidazo [1,2-c][1,2,3] thiadiazole sulfonamides as carboinic anhydrase inhibitors. 7th International Conference on Carbonic Anhydrases: CA Research in the Postgenomic Era. Whitney Laboratory of the University of Florida, St. Augustine, USA. 2006.
  1. Matulis, D., and Todd, M. A. Thermodynamics of sulfonamide inhibitor binding to carbonic anhydrase using titration calorimetry: and interesting effect of protein, ligand, and buffer protonation. Presented at the 58th Calorimetry Conference, Honolulu, USA. 2003 08.
  2. Matulis, D., and Bloomfield, V. Determination of hydrophobic interactions between long aliphatic hydrocarbons: aliphatic amine aggregtion and protonation pKa shift. Presented at the 15th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 2001 09.
  3. Matulis, D., and Bloomfield, V. Determination of hydrophobic interactions between long aliphatic hydrocarbons: aliphatic amine aggregtion and protonation pKa shift. Presented at the 56th Annual Calorimetry Conference, Colorado Springs, USA. 2001 08.
  4. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of cationic lipid binding to DNA by isothermal titration calorimetry. The roles of electrostatics and hydrophobicity. Presented at the 14th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 2000 05.
  5. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of cationic lipid binding to DNA by isothermal titration calorimetry. The roles of electrostatics and hydrophobicity. Presented at 2000 Midwest Thermodynamics and Statistical Mechanics Conference, Minneapolis, USA. 2000 05.
  6. Matulis, D., and Lovrien, R. Protection of enzymes by aromatic sulfonates from inactivation by acid. Presented at the First International Conference on Protein Stabilization, Leeds, Great Britain. 1998 07.
  7. Matulis, D., and Lovrien, R. ANS anion - protein binding primarily depends on ion pair formation. Given at the 42nd Annual Meeting of the Biophysical Society, Kansas City, USA. 1998 02.

 

Poster Presentations at Meetings and Conferences

1.      Gylyte, J., Zubriene, A., Dudutiene, V., Smirnov, A., Timm, D., Manakova, E., Grazulis, S., Matulis, D. „Intrinsic thermodynamics-structure correlations of fluorinated benzensulfonamides as inhibitors of human carbonic anhydrases“. „The Twenty-seventh Annual Gibbs Conference on Biothermodynamics”, 2013 10 05-08, Carbondale, USA.
2.      Petrauskas, V., Gylyte, J., Toleikis, Z., Cimmperman, P., Matulis, D. „Protein-ligand affinity correlation with the ligand binding volume“. „9th European Biophysics Congress“, 2013 07 13-18, Lisbon, Portugal. 
3.      Petrikaite, V., Matuliene, J., Tauraite, D., Villanueva, A., Berdasco, M., Huertas, A., Satein, E. F., Esteller, M., Matulis, D. „Anticancer activity of ICPD compounds in murine models and human cancer cells”. „COST TD0905“, 2013 04 29-30, Reykjavik, Iceland.
4.      Kazlauskas, E., CikotienE, I.,  ZubrienE, A., Matuliene, J., Mikuciauskaite, J., Chaleckis, R., Sharp S., Workman P., Prodromou, Ch, Matulis, D. “ICPD Inhibitor Binding to Human Hsp90 alpha, beta, Full-Length, N-Terminal Domain, Lidless, and Active Site Mutant Isoforms”. „6th International Conference on the Hsp90 Chaperone Machine”, 2012 09 19-23, Les Diablerets, Šveicarija.
5.      Norvaišas P., Petrauskas V., Matulis D. “Thermodynamics of cationic and anionic surfactant interaction”. “XVII International Society of Biological Calorimetry (ISBC) Conference“. Leipzig, Germany. 2012 06 03-06.
6.      Čapkauskaitė E., Zubrienė A., Baranauskienė L., Manakova E., Tamulaitienė G., Kazokaitė J., Kairys V., Gražulis S., Tumkevičius S., Matulis D. „Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases“. „The 9th International Conference on Carbonic Anhydrase (CA)“. Turkey, Antalya. 2012 04 11-15.
  1. Capkauskaite, E., Zubriene, A., Baranauskiene, L., Tamulaitiene, G., Manakova, E., Grazulis, S., Tumkevicius, S., Matulis, D. Synthesis of pyrimidine derivatives as inhibitors of carbonic anhydrase. 23rd International Congress on Heterocyclic Chemistry (ICHC-23). Glasgow, Great Britain. 2011 07 31-08 04
  2. Petrikaite, V., Kazlauskas, E., Matuliene, J., Matulis, D. Anticancer activity and Admet properties of resorcinol – bearing lead compounds. The 47th International Conference „Drug Discovery and Selection“. Lyon, France. 2011 07 06-08
  3. Dudutiene, V, Zubriene, A., Kairys, V., Matulis, D. Probing of the carbonic anhydrase isozyme active center cavities with inhibitor functional groups. International Conference „Frontiers in Medicinal Chemistry“. Stocholm, Sweden. 2011 06 19-21.
  4. Petrauskas, V., Zubriene, A., Kazlauskas, E., Baranauskiene, L., Matulis, D. Intrinsic Binding Parameters as a Necessity to Correlate Energetics with Structure. 19th Biennial Meeting of the International Society for Molecular Recognition. Tavira, Portugal. 2011 06 16-19.
  5. Jogaite, V., Zubriene, A., Gylyte, J., Michailoviene, V., Matulis, D. Inhibitors binding to Recombinant Human CAXII. „FEBS satellite CA meeting“. Montecatini, Italy. 2011 06 22-24.
12.  Matulis, D. Carbonic anhydrase inhibitors as anticancer agents. Molėtai, Lithuania. 2010 06 16.
13.  Toleikis,  Z., Cimmperman, P., and Matulis, D. Determination of The Volume Changes Induced by Ligand Binding to Hsp90 Using High Pressure Denaturation. The 6th International Conference on High Pressure Bioscience and Biotechnology (HPBB2010). Munich,  Germany. 2010 08 28-09 01.
14.  Petrauskas, V., Maksimaviciutė, E., Matulis, D. Thermodynamics of Ion Pair Formations in Proteins. ESBES+ISPPP+ISB. Bologna, Italy. 2010 09 05-08.
  1. Zubriene, A., Kazlauskas, E., Chaleckis, R., Michailoviene, V., Matuliene, J., Matulis, D. Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms. The 5th International Conference on The Hsp90 Chaperone Machine. Les Diablerets, Switzerland. 2010 09 29-10 03.
  2. Petrikaite, V., Kazlauskas, E., Zubriene, A., Michailoviene, V., Matuliene, J., Matulis, D. Resorcinol -  Bearing Hsp90 inhibitors as anticancer agents. COST Action TD09/05 Epigenetics - Bench to Bedside. Brno, Czechia. 2010 11 22-25
  3. Kazlauskas, E., Cikotiene, I., Matuliene, J., Zubriene, A., Jachno, J., Torresan, J., Michailoviene, V., Petrikaite, V., Grinius, L., Matulis, D. Resorcinol class Hsp90 inhibitor binding thermodynamics and the effect on cancerous cells. The 4th International Conference on the Hsp90 Chaperone Machine. Bavaria, Germany. 2008 10 2‑6.
  4. S. Grazulis, L. Baranauskienė, E. Manakova, R. Sukackaitė, D. Golovenko, G. Tamulaitienė, D. Matulis. Novel thiadiazoles inhibitors of human carbonic anhydrases. 7th ScanBalt Forum & Biomaterial Days. Vilnius, Lithuania. 2008 09 24-26.
19.  S. Gražulis, L. Baranauskienė, E. Manakova, R. Sukackaitė, D. Golovenko, G. Tamulaitienė, D. Matulis. Novel thiadiazoles inhibitors of human carbonic anhydrases. XXI Congress and General Assembly of the International Union of Crystallography. Osaka, Japan.  2008 08 23-31.
  1. Cimmperman, P., Toleikis, Z., Matulis, D. A general model to describe protein thermal stabilization and destabilization by ligands. 2nd International Symposium on Biothermodynamics, Frankfurt am Main, Germany.  2008 02 21-22.
  2. Matulis, D., and Todd, M. Thermodynamics of inhibitor binding to carbonic anhydrase by titration calorimetry and ThermoFluor®. Presented at the 16th Gibbs Conference on Biothermodynamics, Carbondale, USA. 2002 09.
  3. Matulis, D., and Todd, M. Thermodynamics of inhibitor binding to carbonic anhydrase by titration calorimetry and ThermoFluor®. Presented at the 57th Annual Calorimetry Conference, New Brunswick, USA. 2002 08.
  4. Matulis, D., Rouzina, I., and Bloomfield, V. Determination of hydrophobic interactions between long chain aliphatic hydrocarbons by titration calorimetry. Presented at the 46th Annual Meeting of the Biophysical Society, San Francisco, USA. 2002 02.
  5. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics cationic lipid binding to DNA by titration calorimetry: the roles of electrostatics and hydrophobicity. Presented at the 45th Annual Meeting of the Biophysical Society, Boston, USA. 2001 02.
  6. Lovrien, R., Wu, C., and Matulis, D. Lectin and protease isolation from crude via coprecipitation matrix ligands. Presented at the American Chemical Society 219th National Meeting, San Francisco, USA. 2000 03.
  7. Lovrien, R. and Matulis, D.. Isolation of proteins from crudes: Matrix entanglement ligand basis.  Presented at the American Chemical Society 219th National Meeting, San Francisco, USA. 2000 03.
  8. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. Presented at the 44th Annual Meeting of the Biophysical Society, New Orleans, USA. 2000 02.
  9. Lovrien, R., Wu, C., and Matulis, D. Forces, energetics, topology of outer directed hydrophobicity in organic ligand-protein matrices. Presented at the 44th Annual Meeting of the Biophysical Society, New Orleans, USA. 2000 02.
  10. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. Presented at the Nucleic Acid Interest Group meeting. 1999 10.
  11. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. Presented at the 13th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 1999 10.
  12. Matulis, D., and Lovrien, R. Prediction of free energies and enthalpies of anionic aliphatic ligand binding to proteins based on experimental database and the enthalpy additivity principle. Presented at the 43rd Annual Meeting of the Biophysical Society, Baltimore, USA. 1999 02.
  13. Lovrien, R., and Matulis, D. Pushing agents, pulling agents in protein isolation. Presented at the 43rd Annual Meeting of the Biophysical Society, Baltimore, USA. 1999 02.
  14. Matulis, D., and Lovrien, R. Thermodynamics of the organic and inorganic anion binding to the strongest site on bovine serum albumin. Presented at the 12th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 1998 10.
  15. Matulis, D., and Lovrien, R. Protection of enzymes by aromatic sulfonates from inactivation by acid. Presented at the First International Conference on Protein Stabilization, Leeds, Great Britain. 1998 06.
  16. Matulis, D., and Lovrien, R. ANS anion - protein binding primarily depends on ion pair formation. Presented at the 11th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 1997 10.
  17. Matulis, D., and Lovrien, R. Alkane sulfates (SDS) bind to proteins by forming ion pairs with the positively charged amino acids. Presented at the 3rd International Conference on Lipid-Binding Proteins, Minneapolis, USA. 1997 05.
  18. Matulis, D., Wu, C., and Lovrien, R. Designing pushing, pulling, hybrid push-pull agents for protein precipitation. Presented at the 41st Annual Meeting of the Biophysical Society, New Orleans, USA. 1997 02.
  19. Lovrien, R., and Matulis, D. Biophysical perspectives on protein precipitation-coprecipitation. Presented at the 40th Annual Meeting of the Biophysical Society, Baltimore, USA. 1996 02.
  20. Lovrien, R. and Matulis, D. Hard and soft sulfate and sulfonate anions in protein precipitation-biorecognition. Presented at the 39th Annual Meeting of the Biophysical Society, San Francisco, USA. 1995 02.
  21.  Matulis, D., Meškys, R., and Rubikas, J. Removal of nickel from industrial effluents: an innovative process using the bacterial membrane transport system for nickel. Presented at the Fourth International Symposium on Biological Processing of Fossil Fuels, Alghero, Italy. 1993 09.
  22. Matulis, D., Meškys, R., and Rubikas, J. Nickel uptake and efflux by bacterial cells. Presented at the International Symposium on Biological Processing of Fossil Fuel in Moscow, Russia. 1991 09.

Academic research projects

  1. VP1-3.1-ŠMM-07-K-009 „Support to Research Activities of Scientists and Other Researcher (Global Grant)“. “Design of selective carbonic anhydrase, Hsp90, and Hsp70 inhibitors and investigation of their anticancer properties”. (405 454 €), 2012 09 02 – 2015 10 01.
  2. Grant No. LIG-09/2012 from the Research Council of Lithuania. (171 021 €), 2012 05 02 – 2014 12 31.
  3. “BPS Mini-Grant Networking Event”. (380 €), 2012.
  4. Baltic Sea Region Programme 2007 – 2013. Baltic Sea Health Region – Business acceleration support and training bridging innovative SMEs and health care organisations to strengthen BSR health economy, BSHR HealthPort. (111 000 €), 2010 09 17 - 2013 12 16.
  5. FP7-REGPOT-2009-1 MoBiLi   "Strengthening  and  sustaining  the  European perspectives  of  Molecular Biotechnology  in  Lithuania".  (1 600 000 €), 2009 12 – 2013 05.
  6. Grant No. LIG-16/2010 from the Research Council of Lithuania. (294 800 €), 2010 09 – 2011 12.
  7. Epigenetics: Bench to Bedside. COST. 2009 – 2013.
  8. Chemical Biology with natural products. COST. 2009.
  9. Anticancer drug design by structural biothermodynamics“ by EEA-Norway Grants (565 037 €), 2008 – 2010.
  10. “Design of specific human carbonic anhydrase inhibitors”, by the Lithuanian Science and Studies Foundation, (362 000 €), 2005 – 2009.
  11. “Drug design by structural thermodynamics”, European Union FP6 Marie Curie international reintegration grant, (80 000 €), 2004 – 2006.

 

 

 

 



Macedonia

Macedonia

Dijana Plaseska-Karanfilska

dijana@manu.edu.mk

Prof Dijana Plaseska-Karanfilska graduated from the Medical School in Skopje, Republic of Macedonia in 1987. She received her PhD from the Medical Faculty, Limburg University, Maastricht, the Netherlands in 1994. She has been employed at the Research Centre for Genetic Engineering and Biotechnology (RCGEB) “Georgi D. Efremov”,Macedonian Academy of Sciences and Arts (MASA) since 1988, where currently she holds a position of senior scientist and Head of the laboratories. Since 2010 she is a professor at the “St. Cyril and Methodius”, Skopje, R. Macedonia and is involved in undergraduate, master and PhD studies at the Faculties of Pharmacy and Natural Sciences.

She has made significant contribution to the molecular characterization of different monogenic diseases in the Republic of Macedonia. She has been engaged in the molecular diagnostics of inherited, malignant and infectious diseases and has contributed to the translation of a number of molecular genetic tests to clinical practice.

She was coordinating the FP7 REGPOT project, entitled “National Reference Centre for Genomics and Proteomics - MACPROGEN”, financed by the European Commission in the period from April 2009 to June 2012. This project has enabled establishment of a technological platform for high throughput genomics and proteomics research in Macedonia and has resulted in strengthening of national and regional research capacities in these fields. Her recent research interest focuses in reproductive genetics, such as male infertility, spontaneous abortion, rapid and non-invasive prenatal diagnosis and breast cancer.



Mexico & Latin America

EBTNA Representative in Mexico and Latin America

Eugenia Olguin Palacios

genaolguin@yahoo.com.mx



Moldova

EBTNA Reprasentative in Moldova

Serghei Sprincean

Dr. Serghei Sprincean is Associate Professor of Bioethics at State University of Medicine and Pharmacy "Nicolae Testemitanu", Chisinau, Republic of Moldova, coordinator of Master Program in National Security at University of Academy of Science of Moldova and Senior Researcher of department of Political Science of the Institute of European Integration and Political Science of Academy of Sciences of Moldova.

Current research interests: Social and political aspects of bioethical issues, improvement of activity of ethical committees in the field of regulation and monitoring of social and biomedical research, enhancement and development of bioethical capacity in developing and low income countries, importance of social and professional interest groups in promoting bioethical values and principles, bioethics as an ideology of public health, political bioethics.



Morocco

EBTNA Represantative in Morocco

Noursaid Tligui, Prof. Dr.

Name: Noursaid TLIGUI                 

Date and place of birth: 12/05/1957 in Tangier, Morocco

Address: Institute Hassan II of Agronomy and veterinary Medicine, Rabat, Morocco

Tel: 00 212 6 66 86 28 63

E-mail : n.tligui@iav.ac.ma

 

Academic diplomas

1982            Doctorate of Veterinary Medicine, I.A.V. Hassan II, Rabat, Morocco           

1992            PhD. in Veterinary Pathology, Department of Pathology University of Minnesota, USA

 

Professional status

 - Professor since 1996

 - Head of the Department of Pathology at the Hassan II Institute of Agronomy        

   and Veterinary Medicine: 2003 – 2010

 - Dean of the Veterinary School at the Hassan II Institute of Agronomy and       

    Veterinary Medicine: 2003 – 2010

 - General Secretary at the Hassan II Institute of Agronomy and Veterinary  

    Medicine: 2013 – 2015

 

Expertise

- FAO expert (2010): report on the standardization and harmonization of the veterinary curricula in the Maghreb countries.

- Islamic Bank for development expert (2010): report on the reinforcement of the capacities of teaching and expertise of the Inter-Etats School of Sciences and Veterinary Medicine in Dakar (Senegal).

- Organization in collaboration with Pr. A. Parodi of a workshop on “Toward a Mediterranean Union for Veterinary Education” held in Alfort (Paris- France): 7th – 8th October 2010. The European commission.

- Coordinator and speaker in several post-graduate training sessions in the field of animal health and veterinary public health.

- Member of the French–Moroccan committee of Agricultural research projects evaluation (PRAD): since 2003-2015. 

- Expert in the field of animal health and member of the Advisory Committee of food safety (COCSSA) (Ministry of Agriculture).

- Member of the Editorial Board of several scientific journals.

 

Professional organizations

- President of the Network of the Veterinary Establishments of the Mediterranean      

  Region (REEV-Med): 2012 - 2016

- Vice president of the National Veterinary Council in Morocco: 2009 – 2013

- Member of the National Veterinary Council in Morocco: 2013 –  

- National Association of Veterinarians of Morocco, Member

- Société Française d’Anatomie Pathologique, Member

- Sociedad Espanola de Anatomia Patologica Veterinaria, Member

- National Association of Animal Production (ANPA), Member

 - Moroccan Association of Avian pathology, Member

Scientific publications and communications

 

PUBLICATIONS

Tligui N. Descriptive anatomy of the spinal cord of the dromedary (Camelus dromedarius). Vet. Thesis. I.A.V. Hassan II. Rabat. 1982.

Tligui N. Ferula communis variety brevifolia intoxication of sheep: A study of the coagulopathy. Ph.D Thesis. University of Minnesota. USA. 1992. 

Najem M et Tligui N. A propos de deux cas de cirrhose hépatique chez le capybara (Hydrochoerus hydrochaeris). Verh. Ber. Erkrg. Zootiere. p: 307-311. 1993.

Tligui N, Ruth GR. Ferula communis variety brevifolia intoxication  of sheep. Am. J. Vet. Res. Vol 55 (11), p 1558-1536. 1994.

Tligui N, Ruth RG and Felice LW. Ferula communis variety brevifolia intoxication in sheep: Plasma ferulenol levels and activity of clotting factors. Am. J. Vet. Res. Vol 55 (11), p 1564-1569. 1994.

Tligui N, El Hamidi  M, Ouhsine A, El Idrissi H. Equine Actinobacillosis (Shigellosis) : report of first cases in Morocco. Actes Inst. Agron. Vet. Vol 14 (4), p 15-21. 1994.

Bouljihad M, Tligui N, El Hamidi M, Salhi M. Spontaneous nodular intra-peritoneal aspergillosis in an african grey parrot (Psittacus Erithacus) in Morocco. Proceedings. European Association of Zoo- and Wildlife veterinarians (EAZWV). May 16-18, Rostock, Germany. p: 269-272. 1996.

Tligui N, El Hamidi M, Kichou F, Bouljihad M. Combined immunodeficiency in Arabian foal: Actes Inst. Agron. Vet. Vol: 16(2). p: 21-26. 1996.

Azrib R, Bouayad H, Tligui N et Kichou F. Cas de mégaoesophage chez le chien. Espace Vétérinaire, N°6, p:13. 1996.

Tligui N, El Haouzi M and El Himer H. Vitamin K therapy of Ferula communis variety brevifolia toxicosis in sheep. Toxic plans and other natural toxicants. Cab International. p: 159-164. 1998

Tligui N, El Hamidi M, AH El Idrissi and Kichou F. La colisepticémie des agneaux : problème sérieux pour l’élevage ovin. L’Espace Vétérinaire. N°15, p:10. 1998.

Tligui N, El Hamidi M, Berrada J, Bengoumi M, Achaaban MR and Karom M. The prevalence of lung lesions in camel at slaughter house in Morocco. Proceedings. Parasitic and infectious diseases in camel. (FAO), Rabat, Morocco, October 26-31, 1999. Actes Editions. p: 73-78. 2000.

Lamchouri F, Settaf A, Cherrah Y, El Hamidi M, Tligui N, Lyoussi B, et Hassar M. Experimental toxicity of Peganum harmala seed. Annales Pharmaceutiques Françaises. 60: 123-129. 2002.

N. Tligui, M. El Hamidi, R. Azrib, J. Berrada. La méningoencéphalomyélite granulomateuse canine : A propos d’un cas. Animalis, Vol 1, N°4. p : 59-60. 2002.

Kay G, Tligui N, El Hamidi M, M. F. Perron. Case report : Grade III mastocytoma in donkey. The Veterinary Record, 152, 266-267. 2003.

F Kichou, N Tligui, A Najjari et M Drissi. Dominantes pathologiques chez les caprins du nord du Maroc : cas de la région de Tétouan. Actes Inst. Agron. Vet. (Maroc) 2003, vol 23 (2-4): 73-79.

Tligui N and F Kichou: Système lympho-hématopoiétique (N. Malikides, D. Hodgson & J. Rose). Manuel de Pratique Equine. Rose and Hodgson. W.B. Saunders Compny. 2004. p: 458-480.

K. El Alali, M.R. Achaaban, B. Vivien Roels, P. Bothorel, N. Tligui and P. Pévet. Seasonal variations in the nycthemeral rhythm of plasma melatonin in the camel (Camelus dromedarius). J. Pineal. Res, 2005; 39: 121-128.

Piro M.; Ouragh L.; Tligui N.; El Kohen M and El Allali K. Estimation of prevalence of the severe combined immunodeficiency disease in Arabian Horses in Morocco by using a DNA test. Proceedings: 9th Congress of the World Equine Veterinary Association. Marrakech 22-26 January 2006.

Bouayad H.; Tligui N.; Gadi A and El Hamidi M. Equine skin tumors study in Morocco. Proceedings: 9th Congress of the World Equine Veterinary Association. Marrakech 22-26 January 2006.

Serrano C., I. Martín-Burriel, J. Lyahyai, C. Acín, J. J. Badiola, N. Tligui, P. Zaragoza Polymorphisms of the PRNP gene in Moroccan sheep.. Veterinary record, 2007;  161, 524-525. 

PiroM., A. Benjouad, N. Tligui, K. El Allali, M. El Kohen, A. Nabich and L. Ouragh. Frequency of the severe combined immunodeficiency disease gene among horses in Morocco. Equine Veterinary Journal. (2008) 40.  

Tligui N, El Houadfi M, El Hamidi M, Boumdine K et Achaal A. Comparative histopathological study of bursa of fabricius in chickens vaccinated with a vector vaccine HVT – VP2 (Vaxxitek) and those vaccinated with IBD intermediates plus vaccines. Proceedings of the XVIth World veterinary Poultry Association Congress. Marrakech, November 8 – 12, 2009. 

El Houafi M & Tligui N. Diffuseness of intermediate plus IBD vaccine (H2512) in broiler chickens reared in cages. Proceedings: XVII Congress of the WVPA. Cancun Mexico 14 – 18 August 2011.

Achaaban M.R, Mouloud M., Tligui NS., El Allali K. The tonsils of the Camel : functional anatomy and histological aspects. Proceedings of 4th Conference of Isocard “ Silk Road Camel: The camelids, main Stakes for Sustainable Development. p:90, 8-12 juin, Almaty, Kazakhstan, 2015.

Tligui N., Chnitta I., Achaaban M.R, Ouassat M., El Allali K. Male genital accessory glands in the dromedary camel : Anatomical and histological studies.  Proceedings of 4th Conference of Isocard “ Silk Road Camel: The camelids, main Stakes for Sustainable Development. p:149, 8-12 juin, Almaty, Kazakhstan, 2015.

M. R. Achaaban, M. Mouloud, N. Tligui, K. El Allali ; Main anatomical and histological features of the tonsils in the camel (Camelus dromedarius); Accepted for publication in the Tropical Anatomical Health Production Journal, 2016.

 

Communications

Ouhsine A, Tligui N, Bakoury M. Descriptive anatomy of the spinal cord of   the dromedary (Camelus dromedarius). National Neuroscience days. September 19-22, Rabat, Morocco,1984.

El Hamidi M et Tligui N. La tremblante des ovins (Scrapie). IX ème Congrès Vétérinaire Maghrébin, Juin, Alger, Algérie, 1991.

Tligui N et El Idrissi A. Cas de yersiniose chez les Agoutis. Journée Nationale sur la        faune Sauvage.09 Mai,  Rabat, Maroc, 1992.

Tligui N. The toxicity of Ferula communis in sheep. American veterinary Medical Association. 129th Annual Meeting. August 1-5, Boston, Massachusetts. U.S.A,1992.

Tligui N, El Hamidi M. Ouhsine A, El Idrissi H. Cases of actinobacillosis in foals. Second International Colloquim on Working Equine. April 20-22, Rabat, Morocco, 1994.

Tligui N, Himer H, El Alaoui M. Antidotal effect of vitamin K in sheep intoxicated with the plant Ferula communis. A.V.M.A. Meeting. July 9-13, San Francisco, USA, 1994.

Tligui N, El Hamidi M. L'encéphalopathie spongiforme bovine: données cliniques et lésionnelles. Journée d'étude sur les encéphalopathies spongiformes humaines et animales. AMESPV.  26 Octobre, Rabat, Maroc, 1996.

Lamchouri F, El Hamidi M, Settaf A, Zaid A, Tligui N, Chakir S et Hassar M. Toxicité aigue et chronique de Peganum harmala. Colloque International sur les substances naturelles. Faculté des Sciences, Avril 25-26, Meknès, Maroc, 1997.

Tligui N, El Haouzi M and Himer H. Vitamin K1 therapy of Ferula communis variety brevifolia toxicosis in sheep. International Symposium on Poisonous Plants. May 19-23, San Angelo, Texas, USA, 1997.

Oukessou M, Tligui N and Bengoumi M. Tilmicosin pharmacokinetics in camel (Camelus dromedarius). Third Annual Meeting for Animal Production Under Arid Conditions. Fac. Agri. Sci. UAE University, May 2-3, Al-Ain, UAE, 1998.

Kichou F, El Hamidi M, Tligui N, Fikri M et Bouslikhane M. Syndrome nerveux chez les ovins. XVIème Congrès Vétérinaire Maghrébin. Mai 6-7, Marrakech, Maroc, 1999.

Tligui N y El Hamidi M. Fotosensibilizacion hepatogena en ovinos de la region de Tiflet (Marruecos). XII Reunion de la Sociedad Espanola de Anatomia Patologica Veterinaria. Junio 14-16, Jaca, Espana, 2000.

Tligui N, Crespeau F, Kichou F and El Hamidi M. First case report of cryptosporidiosis in an Arabian foal with combined immunodeficiency syndrome in Morocco. 18th Meeting of the European Society of Veterinary Pathology. Sptember 19-22, Amsterdam, Netherlands, 2000.

Bouslikhane M, Kichou F, Tligui N. Analyse du risque d’introduction de l’ESB associé à l’importation des bovins au Maroc. Journée Scientifique sur l’Encéphalopathie Spongiforme Bovine « Maladie de la vache folle » : Actualités Internationales et Programme National de Surveillance. 23 Février, Rabat, Maroc, 2001.

Kichou F, Tligui N, El Hamidi M. Recherche de l’Encéphalopathie Spongiforme au Maroc. Journée Scientifique sur l’Encéphalopathie Spongiforme Bovine « Maladie de la vache folle » : Actualités Internationales et Programme National de Surveillance. 23 Février, Rabat, Maroc, 2001.

Tligui N. Epidémiosurveillance de l’Encéphalopathie Spongiforme Bovine (ESB) au Maroc. La première journée médicale de Tanger. 19 Mai, 2001.

Tligui N. Epidémiosurveillance de l’Encéphalopathie Spongiforme Bovine (ESB) au Maroc. IVèmes journées Médicales de Larache. 25-27 Mai, 2001.

Kichou F., N Tligui & M. El Hamidi. Présentation des résultats de recherche de l'ESB au Maroc. Journée Scientifique  sur le Thème : Encéphalopathie Spongiforme Bovine  (Maladie de la Vache Folle) : Actualités internationales et programme national de surveillance. Bureau Régional Zone Nord-Ouest I de l'Association Nationale des Vétérinaires du Maroc, Rabat, 23 février 2001.

Bouslikhane M., F. Kichou & N Tligui - Analyse du risque d'apparition de l'ESB chez les bovins au Maroc. Journée Scientifique  sur le Thème : Encéphalopathie Spongiforme Bovine  (Maladie de la Vache Folle) : Actualités internationales et programme national de surveillance. Bureau Régional Zone Nord-Ouest I de l'Association Nationale des Vétérinaires du Maroc, Rabat, 23 février 2001.

Kichou F., N Tligui & M. El Hamidi. Results of bovine spongiform encephalopathy surveillance in Morocco. Congrès Vétérinaire Maghrébin, Tripoli, Avril 2001.

Kichou F., N Tligui & M. El Hamidi. Results of bovine spongiform encephalopathy surveillance in Morocco. The 10th International Conference of the association for Tropical Veterinary Medicine, Copenhagen, Denmark, 20-23 August 2001.

Sghiri A, Abbassy A.Y, El Idrissi H.A, Tligui N, Tibary A. Endométrites chez la jument : investigations clinique, bactériologique et histopathologique. Journée sur la santé et reproduction chez les équidés. I.A.V. Hassan II. 23 mars 2002.

Tligui N, El Hamidi M, Berrada J, Bengoumi M, Achaaban M, Karom A. The prevalence of lung lesions in dromedary at slaughtrhouse in Morocco. XIV réunion de la Sociedad Espanola de Anatomia Patologica Veterinaria. Leon, 19-21 junio, 2002.

A. Gadi, H. Bouayad, N. Tligui, M. El Hamidi. Contribution à l’étude des tumeurs cutanées chez les équidés. XXème Congrès Vétérinaire Maghrébin, Fès, 8-9 mai 2003.

Taha I, Bouayad H, Tligui N, El Hamidi M, Sghiri A, Azrib R. La stérilisation chimique chez le chien : essai de l’utilisation de l’enbucrilate et du polidocanol. XXème Congrès Vétérinaire Maghrébin, Fès, 8-9 mai 2003.

N. Tligui, F. Crespeau, F. Kichou, M. El Hamidi. First case of cryptosporidiosis in an Arabian foal with immunodeficiency syndrome in Morocco. Proceedings de la XV Reunion de la Sociedad Espagnola de Anatomia Patologica Veterinaria. Cordoba, 4-6 junio 2003.

M. Piro, L. Ouragh, N. Tligui, M. El Kohen, K. El Allali. Estimation of the prevalence of severe combined immunodeficiency disease in Arabian horses in Morocco using a DNA Test. Proceedings of the 9th Congress of the World Equine Veterinary Association. Marrakech 22-25 January 2006.

Bouayad H, Tligui N, Gadi A, El Hamidi M. Equine skin tumors study in Morocco. Proceedings of the 9th Congress of the World Equine Veterinary Association. Marrakech 22-25 January 2006.

Kichou F, Tligui N & El Hamidi M. Les méthodes de diagnostic de l’encéphalopathie spongiforme bovine. Les Séminaires de Recherche de l’IAV Hassan II. Les biotechnologies en Agriculture et en industries agro-alimentaires. Rabat, 4-5 avril 2006.

M. Piro, L. Ouragh, N. Tligui, M. El Kohen, K. El Allali. Etude épidémiologique de l’immunodéficience sévère combinée chez le cheval Arabe au Maroc par des marqueurs moléculaires. Les Séminaires de Recherche de l’IAV Hassan II. Les biotechnologies en Agriculture et en industries agro-alimentaires. Rabat, 4-5 avril 2006.

Tligui N, El Hamidi M, Berrada J, Bengoumi M, Achaaban MR, Karom A. The prevalence of lung lesions in dromedary at slaughterhouse in Morocco. Proceedings of the international scientific conference on camels. Qassim (KSA), 10-12 may 2006.

Achaaban MR, El Allali K, B Vieven-Roels, Bothorel B, Tligui N and Pévet P. Seasonal plasma melatonin profiles in the camel (Camelus dromedarius).  Proceedings of the international scientific conference on camels. Qassim (KSA), 10-12 may 2006.

Tligui N. L’enseignement vétérinaire post-universitaire au Maroc. Conférence sur les organismes statutaires vétérinaires. Madrid, 18-19 mai, 2012.

Tligui N et Parodi AL. The Mediterranean Network of Establishments for veterinary Education (REEV-Med) : Toward an improvement of Veterinary Education in the Mediterranean Region. 4-6 décembre, Foz do Iguazu, Brésil, 2013.

Tligui N. Intérêt des analyses hématologiques en pratique équine. Coférences scientiques du Salon du Cheval d’El Jadida. 16 octobre, 2015.

Tligui N. Epidemilogical situation and eradication programs of rabies in Morocco. One Health Inter-Regional European Conference. Bucharest, Romania, September 22-24, 2016.



Netherlands

EBTNA Represantative in Netherlands

Mark Nuijten

Dr. Mark Nuijten trained as a physician and worked in clinical practice before obtaining an international M.B.A. from Erasmus University, Rotterdam, with a focuson financial management. He obtained his PhD in health economics (2003) on the thesis “In search of more confidence in health economic modelling” at the Erasmus University, Rotterdam. Dr. Nuijten has become one of the top health economic experts over the last decade, reflected in more than 180 publications and leading positions in scientific societies and editorial boards. Dr. Nuijten was Board Director of ISPOR (2002-2004) and Chair of the Management Board of Value in Health (2002-2004). He was member of the Editorial Advisory Board of Value in Health. Dr. Nuijtenis internationally renowned for achievements in mathematical modelling, also reflected in many publications and positive reimbursement decisions in many markets for innovative medications by institutions, like NICE in England.

He is a pioneer in the field of healthcare innovation in biotechnology and nutrition, and has been the first classical health economist successfully applying and developing sales forecast methodologies for valuation of biotechnology companies. For example, developing a Pricing Matrix Model for research in early phase development and a Financial Valuation Algorithm for the assessment of the future sales of a new, innovative medicinal product.

Dr Nuijten is pursuing development of economic modelling and broadening its application in health care and finance. His models successfully contributed to positive reimbursement decisions by health authorities in many countries, (for example, SMC in Scotland, TLV in Sweden, and The National Health   Care Institute in The Netherlands).

He is academic supervisor of PhD programs at the Universities of Maastricht and Groningen in The Netherlands and founder of the ISPOR Special Interest Group on nutrition-economics.

Dr. Nuijten owns and runs A2M (Ars Accessus Medica - http://a2m.nl/), whichprovides international consulting services in health economics, pricing, market access and valuation in biotechnology. A2M is a partner of Minerva, an international health economics consortium. A2M established other global collaborations with key opinion formers in key European markets, the US, Canada and Japan. A2M is comfortable with multi-country projects. The current A2M project portfolio reflects its long-time international coverage with health economic models being developed for Russia, Italy, Mexico, UK, France, Netherlands and Belgium.

Prior to setting up A2M, Dr. Nuijten was a partner with MEDTAP International. As a VP Business Development for Europe he established global Pricing and Reimbursement Consultancy Services for MEDTAP. Before MEDTAP, Dr. Nuijten was a Managing Director of the Quintiles office in the Netherlands.
Selected publications bridging health economics, pricing, market access and valuation

Fugel HJ, Nuijten M, Postma M. Economic viability of Stratified Medicine concepts: An investor perspective on drivers and conditions that favour using Stratified Medicine approaches in a cost-contained healthcare environment.

N Biotechnol. 2016 Dec 25;33(6):860-867. doi: 10.1016/j.nbt.2016.09.00

Mark Nuijten. The Potential Impact of Current and Future Pharmaceutical Policy Changes on Cash Flows for Innovative Medicines. The Journal of Private Equity Vol. 18, No. 1 (WINTER 2014), pp. 34-45

Mark Nuijten, Marja Pronk. Financial Valuation Algorithm for the Assessment
of the Future Sales of a New, Innovative Medicinal Product. The Journal of Private Equity. Summer 2014, Vol. 17, No. 3: pp. 35-44. DOI: 10.3905/jpe

Mark Nuijten. Pitfalls in the Valuation of a Pharmaceutical Company. Journal of Private Equity. Fall 2013, Vol. 16, No. 4: pp. 57–66

Fugel HJ, Nuijten M, Faulkner E. The application of economics concepts to stratified medicine--use of health economics data to support market access for stratified medicine interventions. J Med Econ. 2014 May;17(5):305-11.

Walzer S, Nuijten M, Wiesner C, Kaier K, Johansson PO, Oertel S. Microeconomic surplus in health care: applied economic theory in health care in four European countries. Front Pharmacol. 2013 Feb 18;4:17.

Fugel HJ, Nuijten M, Postma M. Stratified medicine and reimbursement issues. Front Pharmacol. 2012;3:181.

Nuijten MJ, Dubois DJ. Cost-utility analysis: current methodological issues and future perspectives. Front Pharmacol 2011; 2 (1-5): 29.

Nuijten MJ, Van Gelder PH. Concise Equation That Captures the Essential Elements of One-Way Sensitivity Analyses in Health Economic Models. Med Decis Making 2011; 642-649.

Nuijten MJ, Mittendorf T, Persson U. Practical issues in handling data input and uncertainty in a budget impact analysis. Eur J Health Econ 2010; 231-241.

Mittendorf T, Briggs A, Bastida J L, Nuijten M & Persson U. Do Health Politicians Really Listen to Health Economists? - Observations from Europe. ISPOR Connections November/December 2009; 15(6): 15-16

Mauskopf JA, Sullivan SD, Caro J, Mullins CD, Nuijten M,  J, Trueman P. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.Value Health. 2007 Sep-Oct;10(5):336-47.

Nuijten MJ. Pricing matrix model: dealing with uncertainty. Eur J Health Econ. 2007 Dec;8(4):333-7.

Nuijten MJC, Kosa J Pricing of Pharmaceuticals. Assessing the Pricing Potential by a Pricing Matrix Model. Eur J Health Econom 2004; 5:110-115. 

Nuijten MJC. The Application of Free Market Theory to the Health Care Market. Eurohealth Winter 2003/2004; 9(4):13-17.

Nuijten MJC, Kosa J, Engelfriet P. Modeling the Cost-Effectiveness and Budgetary Impact for Subpopulations. European Journal of Health Economics 2003; 4:70-78. 

Nuijten MJC and Rutten F. Combining a Budgetary Impact Analysis and a Cost-Effectiveness Analysis Using Decision Analytic Modelling Techniques. PharmacoEconomics 2002;20(12):855-67.



Norway

This page is under construction



Pakistan

EBTNA Represantative in Pakistan

Attya Bhatti

HoD Healthcare Biotechnology ASAB

Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences & Technology (NUST) Sector H-12, Islamabad, Pakistan

Email: attyabhatti@asab.nust.edu.pk, attyabhatti@gmail.com

Dr. Bhatti is a Human Molecular Geneticist and working as an assistant professor at NUST. She directs an immunogenetics molecular laboratory. She is also Head of Department Healthcare Biotechnology. Dr. Bhatti received her PhD degree in Human Molecular Genetics from the Quaid-e-Azam University, Pakistan in 2007. She is young scientist and has ~9 years of experience working on the molecular genetics of common diseases of public health importance, including coronary artery disease, diabetes type 2, and arthritis.  She has published more than 40 scientific research articles with IF of more than 80 and her team has contributed in the identification of several genes for T2D and rheumatoid arthritis. She has received more than 06 R& D grants and published two book chapters.

 She has been supervised/completed the thesis/dissertation work of many PhD, MS, BS students. Dr Bhatti is also the Founding Editor of NUST Journal of Natural Sciences (ISSN: 2072-46592, 2010-Present).

Our research lab contributes not only toward the enhanced understanding about the functional biology of genetic disorders, but also helps in the field of diagnostic and developments of therapies. The lab is mainly focused on investigation of susceptibility genes that influence important human traits responsible for immunological genetic diseases like rheumatoid arthritis, diabetes type 1 & 2 etc. Overall objective is to understand genetic controls of hereditary diseases, especially those which are specific to immune disorders, and how they may control gene expression. 



Poland

EBTNA Reprasentative in Poland

Ewa Łojkowska

lojkowska@biotech.ug.gda.pl



Portugal

EBTNA Reprasentative in Portugal

Isabel Belo

Isabel Belo concluded the Graduation in Chemical Engineering at University of Porto, Portugal, and concluded the PhD in 2000 in Chemical and Biological Engineering at University of Minho, Braga, Portugal. She is Assistant Professor at the Biological Engineering Department of Engineering School of University of Minho where she collaborates in several Graduation and Master Degrees in Biological and Biomedical Engineering and in Biotechnology. She is a staff researcher of the Centre of Biological Engineering-CEB, belonging to the Biosystems group (https://www.ceb.uminho.pt/biosystems). Isabel Belo is the Director of the Bioprocess and Biosystems Laboratory of CEB and is the Director of the Doctoral Program of Chemical and Biological Engineering of University of Minho. Her main research activities are related to Bioprocess Engineering, particularly bioprocesses development and optimization and fermentation technologies. She supervised 7 Post-Doc researchers, 9 PhD thesis concluded and more than 40 Master students. She participated and coordinated several scientific projects with external financial support. She has published 3 book chapters and 67 articles in scientific international journals with peer reviewing and she is associate editor of scientific journals.



Romania

EBTNA Reprasentative in Romania

Dana Tapaloaga

Dr. Dana Tapaloaga is Full Professor at the Faculty of Veterinary Medicine, Bucharest. She took her PhD in Veterinary Medicine in 2004 in the field of Animal Reproduction Biotechnology, and her MSc in 1999 (Reproduction Bio Techniques and Biotechnologies) and 1996 (Milk production, processing and trading).

Professional teaching experience area: Milk and meat obtaining technologies, Animal Production Systems, Animal Genetics, Animal breeding.

Current Research interests:  laboratory and economic efficiency researches on bull, buffalo and boar semen; computerized studies on bull and boar semen; laboratory technologies for reproduction biotechnology in breeds preserving; morphologic and hormonal modifications in cows with puerperal disorders; certification and preserving the genetic potential in Mangalitza breed by biotechnological methods.

She was a postdoctoral researcher in the field of animal biodiversity at Postdoctoral School for Animal Sciences Biodiversity and Food Sciences Biotechnologies based upon eco economy and bio economy required to eco san genesis at Romanian Academy, member of Romanian Animal Science Association, member of World Poultry Science Association, member of DAGENE (International Association for the Conservation of Animal Breeds in the Danube Region), member of the Academy of Romanian Scientists, the Committee of National Food Security.



Russia

Russia

Victor Revin

Surname: Revin,
Name: Victor
Date of Birth: April 12, 1950.
Position: Head of the Department of Biotechnology, Bioengineering and Biochemistry, Dean of the Faculty of Biotechnology and Biology Ogarev Mordovia State University.
Registered address: Bolshevistskaya Str., 68, Saransk 430005, Republic of Mordovia, Russia
Mobile phone: +7 (927) 2760275
E-mail: revinvv2010@yandex.ru

Career

1. 1977-1997 Head of the Interdepartmental Laboratory of Biophysics, Biological Faculty Ogarev Mordovia State University
2 . 1991 - present - Dean of the Faculty of Biotechnology and Biology ( before 05/07/2014 - Faculty of Biology ) Ogarev Mordovia State University.
3 . 1992 - present Head of the Department of Biotechnology, Bioengineering and Biochemistry, Dean of the Faculty of Biotechnology and Biology Ogarev Mordovia State University

Education and qualifications

1972 Biologist , Ogarev Mordovia State University, Saransk
1977 PhD in Biological Sciences (Biophysics), Moscow State University named MV Lomonosov, Moscow
1982 Associate Professor, Department of Biochemistry , Ogarev Mordovia State University , Saransk
1990 Doctor of Biological Sciences (Biophysics) , Moscow State University named MV Lomonosov, Moscow
1992 Professor of Biophysics speciality , Ogarev Mordovia State University , Saransk
1998 Honored Scientist of the Republic of Mordovia
2005 Honored Scientist of Russia .
2007 Honoured Scientist of the Russian Academy of Natural Sciences

Membership in professional societies:
Since 2003, Headed The Regional Mordovia Office of Russian Biotechnology Society, a member of the Presidium of the Russian State Training and Methodological Association of biological education, a member of EBTNA Executive Committee.



Serbia

EBTNA Representative in Serbia

Viktor Nedović

Dr. Viktor Nedović is full professor at Deptartment of Food Technology and Biochemistry, Faculty of Agriculture, University of Belgrade, Republic of Serbia.

His research areas belong to biotechnology, food technology, and biochemical engineering. As author and co-author he has published over 400 articles, out of which more than 80 papers published in SCI journals and 30 as book chapters. In addition, he has edited four books for the renowned scientific publishers (Kluwer and Springer). His articles have been cited more than 1700 times, his h-index is 23 (Google Scholar). He has been coordinating or participating in more than 50 reserach and networking projects, out of which 30 are international ones, including four FP7, two FP6, five EUREKA projects, four COST actions, etc. He has visited and established cooperation with a dozen of universities and institutes all over the world.

Prof. Viktor Nedović is founder and president of the Serbian Association of Food Technologists (SAFT) and coordinator of Serbian National Technology Platform “Food for Life”. In 2015 he become an associate member of the Academy of Engineering Sciences of Serbia (AESS). Besides it, he is a member of numerous national and international professional and scientific organizations, like: International Society of Food Engineering, ISFE; European Federation of Food Science and Technology, EFFoST (in the period 2007-2011 and again from 2013 he has been the EFFoST Executive Committee member); European Hygienic Engineering & Design Group (General Secretary of Regional Section Serbia), EHEDG; European Academy of Food Engineering (EAFE). Since 2015 he is a member of International Advisory Board of Latvia University of Agriculture.

He has been a member of scientific boards of more then 40 international food and biotechnology congresses. He is organizer of national competition of the best PhD thesis in the field of food engineering and food technology and the member of the international evaluation committee at the European competition, and also initiator and organizer of national student’s competition in the creation of eco-innovative food products, EcoTrophelia Serbia, under the umbrella of EcoTrophelia Europe, where he serves as member of the international jury.

He is also coordinator of Priority Area 7 (PA7) of the EU Strategy for the Danube Region (EUSDR), Knowledge Society, that is related to research, higher education and ICT. 



Slovakia

EBTNA Representative in Slovakia

Prof Juraj Krajcovic

Dr. Juraj Krajčovič is currently Professor of Molecular Biology at the Department of Biology, Faculty of Natural Sciences University of SS Cyril & Methodius in Trnava, Slovakia. Till January 2017 his scientific and pedagogical career was primarily connected with the Faculty of Natural Sciences, Comenius University in Bratislava, Slovakia. Here he graduated in Biology in 1978, obtained his PhD in 1987 and was teaching different subjects in this area to undergraduate and postgraduate students. Within years 1997-2011 he was a director of the Institute of Cell Biology and Biotechnology there. His favorite research object/model organism is the flagellate Euglena gracilis especially its plastids. Current Research Interests: Molecular cell biology; gene structure and expression; protein import into organelles, primarily chloroplasts; molecular diagnostics; molecular evolution, DNA identification of microorganisms, plastids as drug targets; the origin and evolution of the cell; extremophiles, algae as photobioreactors. Teaching activities: General biology, Molecular cell biology, Genetics, Evolutionary biology; Selected chapters in microbiology and biotechnology. 
E-mail:  juraj.krajcovic@ucm.sk; juraj.krajcovic55@gmail.com



Slovenia

EBTNA Reprasentative in Slovenia

Maksimiljan Brus

maksimiljan.brus@uni-mb.si



Spain

EBTNA Representative in Spain

Photobucket Prof Oscar Vicente

Oscar Vicente was born in 1956, in Madrid (Spain), where he graduated in Biochemistry in 1976 and obtained his PhD in 1983, before spending a three-year postdoctoral period at the Friedich-Miescher Institut, in Basel (Switzerland). In 1988, he moved to the Institute of Microbiology and Genetics, University of Vienna (Austria), where he established and led a research group, to work on pollen development and its biotechnological applications, and on the molecular characterization of pollen allergens and plant MAP kinases.

As Assistant Professor, from 1991 to 1996, he was responsible for several courses of Experimental Genetics taught at the Faculty of Sciences. Oscar Vicente returned to Spain in 1996, to join the faculty of the Polytechnic University of Valencia, where he is at present Professor of Biochemistry and Molecular Biology, teaching different subjects in this area to undergraduate and postgraduate students of Biotechnology and Agronomic Engineering. His research interest focuses on the study of plant responses to abiotic stress and stress tolerance mechanisms.



South Korea

EBTNA Reprasentative in South Korea

Nguyen Van Thuan

vanthuan@konkuk.ac.kr



Sweden

This page is under construction



Switzerland

This page is under construction



Turkey

Board in Turkey

Prof Munis Dündar, Coordinator

He was born May 2, 1961. He took undergraduate degree at Erciyes University, Faculty of Medicine in 1985. He made Ph.D. on Medical Genetics at Duncan Guthrie Institute of Medical Genetics, University of Glasgow/Scotland in 1994 and got Professor Title in 2003. He is founder and head of Medical Genetics Department at Erciyes University and he has been currently carrying out various administrative tasks since 1996.

He took part as Project Coordinator and Assistant Investigator in many research projects and many prepared articles out of them have been publishing in international journals since 1995. He is a lecturer at European University Consortium, Job Creation Oriented Biotechnology for first level degree and master program students, since 2006. He was president of the Turkish Medical Genetic Society between 2008-2010 and he is of EPMA in Turkey and EBTNA President (European Biotechnology Thematic Network Association).

Red Biotechnology Board (Health Medical Diagnostics)

Blue Biotechnology Board (AquacultureCoastal and Marine Biotech)

Yellow Biotechnology Board (Food Biotechnology Nutrition Science)

Green Biotechnology Board (Agricultural Environmental Biotechnology Biofuels Biofertilizers Bioremediation & Geomicrobiology)

Brown Biotechnology Board (Arid Zone and Desert Biotechnology)

White Biotechnology Board (Gene-based Bioindustries)

Dark Biotechnology Board (Bioterrorism Biowarfare Biocrimes Antcrop warfare)

Members
Aygül Ekici
Ahu Altınkut Uncuoglu
Munis Dündar
Feride Şahin
Hilal Akalın
Hande Yapışlar
Haydar Bağış
Hilal Özdağ
İlhan Demirhan
Muge Sirvani
Nazife Tascioglu
Nurdan Tozun
Selma Ozturk
Sevnur Mandaci
Ahmet Okay Caglayan
Seher Polat
Tijen Ogras
Tayfun Ozcelik
Turgay Tekinay
Ugur Ozbek
Yagut Akbarova
Oguzhan Bahadır



Ukraine

EBTNA Reprasentative in Ukraine



United Kingdom

United Kingdom

Prof Kevan Gartland

Vice President

Professor Kevan MA Gartland is currently Special Advisor and Professor of Biological Sciences at Glasgow Caledonian University, Glasgow, Scotland, President of the Heads of University Centres of BioMedical Sciences and Honorary Professor in the Department of Health Technology and Informatics, the Hong Kong Polytechnic University. After degrees in Genetics (BSc, Leeds) and PhD in Molecular Biology and Biotechnology (Nottingham) he was British Technology Group Research Fellow (Nottingham University), before taking up a Lectureship in Biotechnology & Molecular Biology at De Montfort University. Senior Lectureship, Head of Division and Associate Head of School posts followed, as did a Personal Research Chair in Biological Sciences at the University of Abertay Dundee, where he established a thriving research group in applications of the biosciences to the environment. This culminated in his being Founding Director of the Abertay Centre for the Environment (ACE), receiving £2.4M EU funds and taking an entrepreneurial approach to the uses of the biosciences to meet the needs of businesses, whilst also working with the United Nations Environment Programme. He moved to Glasgow Caledonian University in 2005, serving as Dean of the School of Life Sciences until 2011. He has previously been a University of Abertay Court member, Heads of University Biological Sciences Executive Committee member, Education Committee Chair and a Director of the Biochemical Society, a Director of the Institute of Forest Biotechnology, based in North Carolina, USA, Chair of the Higher Education Academy Biosciences Subject Centre, and Director or Trustee of several companies and charities. He is a Fellow of the Royal Society of Biology and of the Institute of BioMedical Science.  He has contributed to a Hong Kong Poly University MOOC studied by 48,000 students from 177 countries. He is frequently in demand as a reviewer, editor and adviser on applications of the molecular biosciences, quality assurance, learning & teaching and new programme developments. He has recently been appointed as an Academic Assessor for the UK Teaching Excellence Framework, looking at the quality of teaching, learning resources and student outcomes in UK higher education.



United States of America

United States of America

Prof. Lal Ratnesh

Prof. Lal received his MS/M Phil in Physics/Biophysics from JNU, India, Ph.D. in Neurobiology from UAB, and postdoctoral training at Caltech. He held faculty positions at the University of Chicago and UCSB and then the Director of the Center of Nanomedicine and professorships in Medicine, Biophysical Sciences and Cell Physiology at the University of Chicago. Currently, he holds joint professorships in Bioengineering, Mechanical Engineering, and Materials Science, and is the co-Director for the Center for Excellence in Nanomedicine and Engineering at UCSD. He is a Fellow of AAAS (the American Association for Advancement of Science) and a Fellow of the American Institute of Medical and Biological Engineering (AIMBE). He was the UTS Invited Professor in Sydney for their Bionanotechnology initiative and a New Zealand Government International Science Scholar. He is a Visiting Professor at the Chinese Academy of Sciences, Institute for Applied Physics, Shanghai. He is an Associate Editor of the Journal Nanomedicine: Nanotechnology, Biology, Medicine. He is the Chairman of American Nanoslutions, LLC, Vessel ANI corp and is on advisory board of RC Nano LLC and Be Green Packaging LLC. He has presented many international keynote lectures and is featured in many popular magazines and news media, including Time and Smithsonian. He holds several patents based upon AFM cantilever arrays, microfluidics, optoelectronics and nanotubes for medical diagnostics, Nano biosensors and in-vivo medical Nano devices, nanoscale fluid behavior and new TIRF, FRET and related optical microscopy